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ABSTRACT 
 
Lung cancer is the leading cause of cancer-related death in the United States and 
worldwide. Early detection of lung cancer can help improve patient outcomes, and survival 
prediction can inform plans of treatment. By extracting quantitative features from computed 
tomography scans of lung cancer, predictive models can be built that can achieve both early 
detection and survival prediction. To build these predictive models, first a detected lung nodule 
is segmented, then image features are extracted, and finally a model can be built utilizing image 
features to make predictions. These predictions can help radiologists improve cancer care. 
Building predictive models based on medical images is the basis of the budding field of 
radiomics. The hypothesis is that images contain phenotypic information that can be extracted to 
aid prediction and that automated methods can detect some things beyond human detection.  
With improved detection and predictive models radiomics aims to help assist radiologists and 
oncologists provide personalized care.  
 In this work a model is presented to predict long term survival versus short term survival. 
Forty adenocarcinoma diagnostic lung computed tomography (CT) scans from Moffitt Cancer 
Center were analyzed for survival prediction. These forty cases were in the top and bottom 
quartile for survival. A decision tree classifier was able to predict the survival group with an 
accuracy of 77.5% using five image features chosen from 219 using relief-f.  
 Another contribution of this work is a model for predicting cancer from suspicious 
nodules. The national lung screening trial was used to build a training set of 261 screening CTs 
and a test set of 237 CTs. These images were taken at the initial screening, one and two years 
	viii 
before cancer developed. From these precursor images, which nodules developed into cancer, 
could be predicted at 76.79% accuracy with an area under the receiver operating characteristic 
curve of 0.82.  A risk score was also developed to provide a measure of risk during screening. 
The developed risk score performed favorably in predictive accuracy compared to Lung-RADS 
on this data set.  
 The Data Science Bowl was also entered and this work examines the knowledge gained 
from a large-scale competition to improve imaging. In this competition participants were tasked 
with predicting cancer from 1397 training cases on 506 test cases. The winning entry performed 
with a logLoss of 0.39975 while making use of all the training data while our entry scored 
1.56555 with a different set of training data. A lower logLoss shows greater accuracy. This work 
explains our approach and examines the winning entry.  
An overview of the state of radiomicis as it applies to lung cancer is also provided. These 
contributions of predictive models will help to provide decision support to medical practitioners. 
By providing tools to the medical field the goal is to advance automated medical imaging to aid 
clinicians in creating diagnosis and treatment plans. 
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CHAPTER 1: INTRODUCTION 
 
1.1 What is Radiomics? 
In “Radiomics: Images Are More than Pictures, They Are Data” by Gillies et al. ,1 
radiomics is defined as the “high-throughput extraction of quantitative features that result in the 
conversion of images into mineable data and the subsequent analysis of these data for decision 
support.” Radiomics differs from computer-aided diagnosis and detection (CAD) systems. While 
both use medical images from computed tomography (CT), magnetic resonance (MR), and 
positron emission tomography (PET), CAD systems are designed to detect or diagnose a disease. 
Radiomics, on the other hand, extracts and stores features for hypothesis testing and to develop 
decision support tools. Radiomics is intended to supply imaging biomarkers for disease 
detection, diagnosis, prognosis, treatment prediction, and monitoring.  Radiomics has grown 
around oncology due to the support of the National Cancer Institute and the Quantitative Imaging 
Network, but can be used for any disease. The workflow consists of imaging the patient, 
identifying regions of interest (segmentation), feature extraction, and data mining and model 
building. Images acquired are standard of care images. Regions of interest can be the whole 
tumor or just parts, known as habitats. Features extracted can be semantic or agnostic. Semantic 
features are what radiologists commonly use to describe lesions such as shape, location, 
vascularity, spiculation, necrosis, and attachment. These features can be quantified with the aid 
of a computer as well. Agnostic features are mathematical descriptions, such as histograms of 
intensity, Laws features, and wavelets. The features are stored in databases. These databases 
must have enough patients so that the studies and models built have enough power to be 
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generalizable, but the data should also be of high quality and well curated. Once the data is 
gathered, data mining/machine learning, and statistical approaches can be applied. Challenges for 
radiomics include problems of reproducibility, data size and sharing, and deciding on standards 
for analysis. These problems can be overcome and in the reading room of the future a radiologist 
will have access to information gleaned from radiomics while new information is automatically 
shared.  
 Besides image features, plasma based microRNA signatures are another source of 
biomarkers for lung cancer. Sozzi et al. built a microRNA signature classifier (MSC) and tested 
it retrospectively on data from the Multicenter Italian Lung Detection (MILD) trial.2 The authors 
were able to obtain an 87% sensitivity and an 81% specificity in detecting lung cancer. This was 
better than the low-dose computed tomography (LDCT) results of 79% sensitivity and 81% 
specificity. However, the predictions were done at the time of diagnosis and it is unknown how 
they would perform across a wider time gap. 
 The four advances that led to the rise of radiomics, according to Lambin et al., are 
innovations in medical devices, innovations in imaging agents, standardized protocols allowing 
quantitative imaging, and innovations in imaging analysis.3 The authors define radiomics as “the 
high-throughput extraction of image features from radiographic images” with the goal of 
inferring proteo-genomic and phenotypic information.  
Better medical devices allow for viewing finer details of tissue composition. Improved 
imaging agents can reveal pathological processes such as hypoxia marking in PET imaging. 
Standardization, which still needs improvement, allows for reproducible results. With better 
analysis of results, better computer-assisted detection systems can be produced. These 
innovations will allow for advances in radiomics. 
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1.2 Why Radiomics Matters – A Lung Cancer Perspective 
As of 2017, lung cancer is the second most commonly diagnosed cancer and the leading 
cause of cancer related deaths in both men and women.4 Screening is known to reduce mortality 
in lung cancer for long-term smokers. In fact, screening with low dose spiral computed 
tomography has been shown to reduce mortality by 20% compared to using chest x-rays in adults 
with a history of smoking. Screening finds nodules in the lungs, which may become cancer. 
Screening is important and can be improved through radiomics. Zhu et al. showed that a support 
vector machine compared favorably to radiologists when classifying solid pulmonary nodules.5 
Radiomics provides a way for images to be analyzed in a standardized manner and can provide 
prognostic information.6 Radiomics is a non-invasive tool for diagnosis and can be easily 
incorporated into current medical imaging practices. CT images also provide a picture of the 
whole lung nodule, whereas a biopsy is at a specific part of a nodule and cancer is not believed to 
be homogeneous.  
1.3 Contributions  
This dissertation is based upon the previous work done in radiomics. The design of image 
feature extraction and model building for prediction is informed from the work by the likes of 
Way et al. who distinguished benign and malignant nodules from texture features.7 Zhu et al. 
showed the value of support vector machines in classifying malignant pulmonary nodules, which 
is an approach used in this dissertation.5 Aerts et al.’s workflow of CT imaging, feature 
extraction, and analysis is similar to the workflow used in this work.6 This dissertation seeks to 
build upon previous research that has already been shown to work.   
This dissertation outlines a model for predicting survival. Adenocarcinoma cases were 
predicted at the time of diagnosis into short-term or long-term survival classes. A decision tree 
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classifier using the top five of 219 features selected per fold in a leave-one-out cross validation 
was able to obtain an accuracy of 77.5%.8 This was the first study to predict survival at time of 
diagnosis using image features on a heterogeneous data set. The data from this study is available 
at The Cancer Imaging Archive.9 
This dissertation provides a model for predicting the malignancy of lung nodules. Using 
two cohorts10 of baseline screening CTs from the National Lung Screening Trial (NLST),11 we 
were able to predict whether a nodule would become cancerous within 1 year at 80% accuracy 
and if a nodule would become cancerous within 2 years at 79% accuracy.12 The Radiomics 
model outperformed the Lung Imaging Reporting and Data System (Lung-RADS)13 as well as 
outperforming a prediction from volume alone. A novel risk score was generated from this 
model, which was better than any we could find. 
While there are still many challenges to be met in every step of a radiomics workflow as 
outlined by Kumar et al.,14 such as different scanner types and trouble sharing data, these 
challenges will be overcome and present many opportunities for innovation. The research 
reported here provides a new baseline.  
1.4 Dissertation Organization 
Chapter 2 provides background information on lung cancer, radiomics, segmentation, 
feature selection, classification, and metrics for analysis.  Chapter 3 applies radiomics to predict 
survival of non-small cell lung cancer using CT image features. Chapter 4 predicts malignancy 
of lung nodules from screening CT scans. Chapter 5 discusses the Data Science Bowl 2017. 
Chapter 6 provides concluding remarks.  
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CHAPTER 2: BACKGROUND 
 
2.1 Lung Cancer 
The leading cause of cancer-related death in the United States and worldwide is lung 
cancer.15,16 Any improvement in outcome will help a large number of people. In 2016, lung and 
bronchus cancer were estimated have the most deaths for both men and women, but also had the 
second most new cases for both sexes too.17 There were an estimated 224,390 new cases of lung 
cancer in 2016 accounting for 14% of cancer diagnoses. Smoking is the primary risk factor 
accounting for 80% of lung cancer deaths in the US. Symptoms of persistent cough, blood in 
sputum, chest pain, shortness of breath, and recurrent pneumonia and bronchitis are not usually 
present until the cancer has advanced.  
For this reason early detection for at risk patients is important. Screening with low-dose 
spiral computed tomography (LDCT) can reduce mortality by 20%.11 The type of lung cancer 
determines treatment options.  
Early stage non-small cell cancer is treated with surgery. Later stage non-small cell 
cancer is treated with chemotherapy, targeted drugs, or immunotherapy. Small cell lung cancer is 
treated with chemotherapy or radiation. Overall one-year survival is 44% while five-year 
survival is 17%. Small cell lung cancer, which accounts for 13% of cases, has a five-year 
survival of 7%. Non-small cell lung cancer, which accounts for 83% of cases, has a five-year 
survival of 21%. 
 Oberije et al. did a prospective study comparing the predictions of doctors to models for 
treatment outcomes of non-small cell lung cancer patients.18 Radiation oncologists predicted 2-
	 6 
year survival after the first consultation for 121 patients and predicted 2-year survival after a 
radiation treatment plan was made for 35 patients. For doctors the AUC was 0.56 after 
consultation and 0.56 after the treatment plan. The model had an AUC of 0.71 and 0.78. These 
results were statistically significant at the 0.05 level, and the authors concluded that clinicians 
would benefit from decision support systems. 
2.1.1 Lung Image Reporting and Data System (Lung-RADS) 
The current method for lung nodule classification is the lung image reporting and data 
system (Lung-RADS) which was developed by the American College of Radiology (ACR).13 
The categories that cases are assigned into are Incomplete (0), Negative (1), Benign Appearance 
(2), Probably Benign (3), Suspicious (4a, 4b, 4x), Other (S), and Prior Lung Cancer I.   
Nodules are considered benign if they are less than 6mm or new and less than 4mm for 
solid nodules. If they are part solid nodules, less than 6mm is considered benign. For non-solid, 
ground glass, nodules, less than 20mm or greater than 20mm and not growing is considered 
benign. Suspicious nodules are defined as greater than or equal to 8mm or new and greater than 
6mm for solid nodules. For part solid nodules greater than or equal to 6mm are considered 
suspicious.  
The recommended management is annual screening for benign appearance nodules, 6 
month LDCT for probably benign nodules, 3 month LDCT for 4a suspicious nodules, and chest 
CT or PET for 4b and 4x suspicious nodules. The probability of malignancy for benign 
appearance nodules is less than 1%; this accounts for 90% of the population.  
For probably benign nodules the probability of malignancy is 1-2%, and the population 
percentage is 5%.  Suspicious 4a nodules have a 5-15% chance of malignancy and account for 
2% of the population. Suspicious 4b and 4x nodules have a greater than 15% chance of 
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malignancy and account for 2% of population. These categories helped to standardize lung-
screening interpretations. 
Pinsky et al. scored Lung-RADS on the National Lung Screening Trial as part of a 
retrospective study.19 Lung-RADS performed favorably compared to the screening criteria in the 
NLST protocol, which considered a positive screen to be if a nodule was greater than 4mm. At 
baseline Lung-RADS had a false positive rate of 12.8% whereas the NLST protocol had a false 
positive rate of 26.6%. However, sensitivity was also reduced. At baseline the sensitivity using 
Lung-RADS was 84.9% compared to 93.5% in NLST.  
The authors concluded that the reduction in the false positive rate was weighted towards 
lower risk individuals and that 5-year survival did not differ. This could lead to reduced harm 
and cost by using the Lung-RADS criteria, but a study would be needed that was not 
retrospective. 
2.1.2 McWilliams Model 
McWilliams et al.20 proposed another model for predicting malignancy in baseline lung 
nodule CT scans. This model, also known as the Brock University cancer prediction equation, 
uses age, sex, family history, emphysema, nodule size, location, solidity, count, and spiculation 
to make a prediction.  
The model divided prediction into low risk (5% chance of developing cancer), medium 
risk (5% to 10% risk), and high risk (more that 10% risk). McWilliams et al. tested their model 
on the Pan-Canadian Early Detection of Lung Cancer Study and found their model to have an 
area under the receiver operating characteristic curve (AUC) of 0.9. This study showed that for 
20% of the participants the largest nodule was not the malignant one on follow-up. By utilizing 
more clinical factors they were able to produce an accurate model.  
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2.2 Lung Cancer Radiomics 
2.2.1 Historical 
In 2003 Kido et al. analyzed internal and peripheral textures of adenocarcinoma and 
squamous cells using fractal analysis.21 The data set consisted of thin-section computed 
tomographies from 70 patients. The authors were able to differentiate bronchioloalveolar cell 
carcinomas (BACs), which have a good prognosis, from other bronchogenic carcinomas 
(nonBACs). It should be noted that bronchioloalveolar carcinoma is a classification no longer in 
use. The term has been replaced with adenocarcinoma in situ and minimally invasive 
adenocarcinoma for small adenocarcinomas and invasive mucinous adenocarcinoma for large 
adenocarcinomas.22 The fractal dimensions from BACs were greater than those from nonBACs. 
The authors concluded that the greater fractal dimensions (FDs) for the BACs corresponded to 
more complex structures, which could be used for prognosis. 
In 2006 Way et al. attempted to distinguish between benign and malignant nodules using 
3D active contours.7 Using a data set of 96 nodules the model was based on 2D active contours 
with the addition of 3 different 3D components: 3D gradient, 3D curvature, and mask energy.  
Using leave-one-out resampling the CAD system achieved an AUC of 0.83. 
 In 2007 Segal et al. correlated image features with global gene expressions in 
hepatocellular carcinoma.23 Using CT scans of liver cancer 138 image traits were identified and 
filtered using a Pearson’s correlation cut-off of 0.9 to reduce to 32 traits. There were 28 of those 
32 image traits that were informative of gene expression. The training set included 28 human 
hepatocellular carcinomas (HCCs) with 6,732 genes and the test set had 19 HCCs. The 28 image 
traits predicted variation in expression of 5,282 of the 6,732 genes (78%). The authors concluded 
that genomic activity in the liver could be monitored with noninvasive imaging. 
	 9 
In 2008 Al-Kadi and Watson were able to differentiate between aggressive and non-
aggressive malignant tumors (high and low metabolic).24 Fifteen patients were injected with 
fluorodeoxyglucose, a contrast agent, and at least 11 time-sequenced CT images were analyzed 
for fractal texture. This method yielded 83.3% accuracy in identifying tumor aggressiveness.  
In 2009 Samala et al. looked for the optimum image features in thin section thoracic 
computed tomographies for use in computer-aided design (CAD) systems.25 The authors 
compared the correlation between 11 calculated image features to 9 radiologist-annotated 
features from 42 regions of interest of 38 patients. Of the 11 calculated image features 3 were 
found to be redundant for both nodules and non-nodules. A combination of features performed 
better in classification with a neural network than radiologist annotation alone. Using the 
optimum combination of features, which included sphericity, area, maximum contrast, and 
maximum eccentricity, the authors obtained the maximum F-test of 0.821 and 0.643 for 
malignant and benign nodules compared to other feature sets. They concluded that calculated 
features should be considered for CAD systems and must be evaluated on the total impact that 
those features have.  
In 2010 Ganeshan et al. found that textures in CT images of non-small cell lung cancer 
correlated with glucose metabolism and cancer stage.26 Images were first filtered using a 
Laplacian of Gaussian spatial band filter into fine (2 pixels, 1.68mm), medium (6 pixels, 
5.04mm), coarse (12 pixels, 10.08mm), and unfiltered. Then the mean grey level, entropy and 
uniformity texture features were extracted. With 17 patients the authors found that coarse texture 
features correlated with standardized uptake value of fluorodeoxyglucose and fine texture 
features correlated with stage. This study gave an early indication that texture image features 
could be prognostic about non-small cell lung cancer. 
	10 
 In 2010 Lee et al. developed a two-step CAD system for the identification of benign and 
malignant pulmonary nodules.27 It was tested using leave-one-out cross validation on 125 
nodules. The authors’ ensemble method, which combined a genetic algorithm28 for feature 
selection and a random subspace method,29 was able to perform better than using either approach 
individually with classification using linear discriminant analysis.   
 In 2010 Zhu et al. showed how support vector machines30 could improve classification of 
solitary pulmonary nodules (SPNs).5 Using 77 biopsy-confirmed CT cases of SPNs, 67 features 
were extracted and selected down to 25 using a genetic algorithm.  
The classification results of the support vector machine were compared to six senior 
radiologists. The authors did not find a significant difference when comparing linear, Gaussian, 
polynomial, and sigmoid kernels. They found that the support vector machine performed 
favorably to radiologists obtaining an AUC of 0.8748 compared to 0.8178 for senior radiologists 
with 20 years of experience and 0.7640 for junior radiologists with 2 to 5 years of experience.  
Support vector machines also used many of the same features for decision making as the 
radiologists. 
2.2.2 Contemporary  
In the 2012 paper “3D Slicer as an image computing platform for the Quantitative 
Imaging Network” three institutions explained how they used the 3D slicer imaging software.31 
3D Slicer is an open-source application for clinical practice; similar to a clinical workstation it 
provides visualization, segmentation and registration, but 3D Slicer is also a programming 
platform allowing for data communication, visualization, and user interface development. 
Brigham and Women’s Hospital uses 3D slicer for the visualization of parameters from the 
prostate mpMRI data set. The University of Iowa used 3D Slicer for measuring PET-imaging-
	11 
based quantitative indices in a tumor region. Massachusetts General Hospital used 3D slicer to 
analyze therapeutic response in glioblastoma multiforme. 3D Slicer has been applied to many 
organs and imaging modalities.  
“Effect of Texture Features in Computer Aided Diagnosis of Pulmonary Nodules in Low-
Dose Computed Tomography” in 2013 by Henry Krewer et al. used the LIDC data set to predict 
malignant and benign pulmonary nodules.32 The authors obtained an accuracy of 87.88% 
combining shape and texture features, an improvement over shape features alone.  
Aerts et al., in 2014, promoted the thinking that tumor phenotypes could be visualized 
non-invasively using medical imaging.6 They studied 1,019 lung and head-and-neck cancer 
patients extracting 440 image features composed of intensity, shape, texture, and wavelet 
categories. Using unsupervised clustering, the authors found three clusters of patients and found 
a significant association with primary tumor stage, general tumor stage and histology. The 
authors found a significant difference in survival for 238 features when the median feature of 
their Lung1 data set was compared to the Lung2 validation set. There were 66 features from 
Lung1 that were prognostic of survival on Lung2, Head and Neck1, and Head and Neck2. A 
radiomics signature was proposed consisting of statistics energy (density), shape compactness 
(shape), grey level nonuniformity (heterogeneity), and wavelet grey level nonuniformity 
(heterogeneity). The proposed signature was validated using the concordance index and showed 
better prognostic performance than volume as well as better or comparable performance than 
TNM staging. The four signature features also had significant associations with different gene-
expression profiles indicating they describe different biologic mechanisms.  
Shen et al. used a multi-scale convolutional neural network to extract features for 
classifying benign and malignant nodules in 2015.33 This method uses nodule patches instead of 
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segmentations. The patches were cubes of 96, 64, and 32 pixels surrounding the nodule. These 
patches were input into a multi-scale convolutional neural network.  
To test accuracy, 1375 nodules with approximately a 2:1 benign to malignant ratio from 
the Lung Image Database Consortium and Image Database Resource Initiative34 were used in a 
five fold cross validation. The authors found a classification accuracy of 86.84% using a random 
forests classifier and concluded that their proposed method provided descriptive features using 
patches.  
In 2016, Wu et al. explored classifiers’ ability to predict histology, which could be used 
to determine treatment of lung cancer.35 The authors used a data set consisting of 152 
adenocarcinoma patients and 51 squamous carcinoma patients from the MAASTRO clinic in 
Maastricht, the Netherlands, for training. For testing, the authors used CT images from 62 
adenocarcinoma patients and 90 squamous carcinoma patients from Radboud University Medical 
Center in Nijmegen, the Netherlands. For classification, 440 3D image features were used from 
CT images that were collected before the patients were treated with radiotherapy or 
chemoradiation. Using univariate analysis, 53 features correlated with histology. Three 
classifiers were explored, Naïve Bayes, Random Forests with 100 trees, and K-nearest neighbors 
with K set to 9. The authors tried 24 different feature selection methods with Relief-f having the 
top AUC for all three classifiers. The highest AUC was 0.72 obtained with a Naïve Bayes 
classifier with five features found using Relief-f. The authors concluded that while the 
classification showed promise, a prospective study was needed that incorporated clinical and 
genomic data.  
Lee et al. gave a thoughtful overview of radiomics in 2016.36 The authors defined 
radiomics as “a field of study in which high-throughput data is extracted and large amounts of 
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advanced quantitative imaging features are analyzed from medical images” consisting of 
identifying regions of interest, extracting features, and building predictive models. Lung cancer 
is a genetic disease that results in unchecked cell proliferation. Genomic heterogeneity exists 
within a single tumor which gives rise to tumor habitats. Precision medicine should be able to 
identify the treatment responses for all of the tumor habitats. Radiomics provides a method for 
examining these habitats across time and non-invasively in a way that is impractical with 
multiple biopsies.  
The authors define four types of radiomic features related to specific aspects of a tumor. 
Morphological features describe the physical aspects of a tumor such as shape and volume. 
Statistical features are comprised of histogram and texture features. Regional features describe 
subregions within a tumor. Model-based features include fractal dimensions, which describe 
intrinsic shape. Radiogenomics match radiomic phenotypes to genomic information. The 
challenges for radiomics as a developing field include a reliance on retrospective studies, feature 
variability, differing imaging techniques, study replication, and incorporating other information 
such as clinical, pathological, and genomic information. 
In 2016 Fave et al. looked for the best way to calculate radiomic features.37 The authors 
compared three preprocessing methods and studied how they affected a feature’s dependence on 
volume and prognostic ability. There were 134 non-small cell lung cancer patients with CT 
images used.  The filtering methods applied were 8 bit depth resampling, Butterworth smoothing, 
both of those filters, and no filter. Of the features considered, five features were entirely volume 
dependent: busyness, coarseness, grey-level non-uniformity, run-length non-uniformity, and 
energy. Most of the features, 39 of 55, had at least one preprocessing technique that resulted in 
significant prognostic value as measured with Cox proportional hazard models. Four features had 
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significant prognostic value regardless of the preprocessing technique: high grey-level run 
emphasis, low grey-level run emphasis, histogram mean, and coarseness. The authors concluded 
that smoothing using a Butterworth filter increased prognostic value but also increased the 
volume dependence of the feature. 
In 2016 Scrivener et al. gave an overview of 22 articles in radiomics.38 The authors 
outlined the workflow of radiomics as image acquisition, identifying volumes of interest, 
segmentation, feature extraction, and model development and validation. They note that 
radiomics has a risk of overfitting a large number of features to a small amount of data. Also 
only 5 of the articles reviewed were externally validated. Still the authors concluded that 
radiomics has great potential both in diagnosis and prognosis of lung cancer.  
2.2.3 Challenges of Radiomics 
In the 2012 article “Radiomics: the process and the challenges” Kumar et al. outlined the 
various challenges present when applying radiomics.14 These were divided into each of the steps 
necessary for classification.   
Image acquisition and reconstruction, the first step, has a choice of different models and 
parameters of the scanners causing variances in slice thickness and reconstruction. Also, there is 
difficulty obtaining large data sets with sufficient patients with similar types and stages of 
disease to power studies. The first issue can be combated with studies to identify features that are 
stable across patients and time.  As well as, transforming images to a common thickness and 
field of view.  The second issue can be dealt with through cooperation between institutions and 
by sharing data.  
The second step is segmentation, dividing the images into tumor and normal tissue. The 
challenge is that there is no definitive answer to the question of what is the correct segmentation 
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and even experienced radiologists’ segmentations differ from one another. A possible solution is 
that automated methods can provide, at least, a consistent segmentation.  
The third step is feature extraction. Features can be divided into various categories 
including tumor intensity histograms, shape based features, and texture based features. A large 
number of features can be derived. In order to reduce the number of features to those that are 
reproducible, informative, and non-redundant, it is suggested to use test-retest to look for stable 
features, a cut-off for dynamic range, and correlation.  
The next step is data sharing. Data must be de-identified in order for it to be shared. Data 
used by researchers is often different from that used by clinicians. Metadata may also need to be 
stored. The final step is analysis where findings are sought to aid clinical practice. A problem 
with analysis is that there are many tests that can be performed, but the size of the data is fairly 
small. To help account for false positives a Bonferroni correction can be applied. These are the 
foreseeable problems to be overcome in radiomics. 
2.3 Lung Cancer Segmentation 
Before features are extracted from an image, the image is segmented to delineate the 
nodule from the background. The lung is also segmented which allows for features about how 
attached the nodule is to the lung. In “Automated delineation of lung tumors from CT images 
using a single click ensemble segmentation approach” Gu et al. present in extension of the “Click 
and Grow“ algorithm.39 The “Click and Grow” algorithm is semi-automated, requiring a starting 
point from a user, then expands the boundary of the segmentation until an intensity cutoff criteria 
is met. To overcome the problems of inconsistent segmentations, multiple human interactions, 
and unsatisfactory boundaries of the “Click and Grow” algorithm an ensemble method was 
proposed. The ensemble method first uses “Click and Grow” to get an initial boundary, then 
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selects random seed points within the boundary. These new seed points are used to grow children 
regions. These regions are compared to the initial segmentation for intensity mean, standard 
deviation, shape, and connection to the main tumor.  If those criteria are met, the new 
segmentation is merged. The ensemble method required less human interaction in cleaning up 
segmentations and also had better agreement between two different users.  
 Another way to segment an image is Otsu’s method.40 In this method shades of grey, grey 
levels, are separated into foreground and background, or as applied to our segmentation problem, 
nodule and lung. The grey levels are differentiated based on a threshold with all pixels below the 
threshold belonging to one class and all pixels above the threshold belonging to the other class.  
The threshold is chosen so that it maximally separates the two classes of pixels, this is an 
optimization problem to minimize the within class variance, maximize the between class 
variance, and minimize the total variance levels. When a threshold is found then the nodule is 
segmented.  
 Gomathi and Thangaraj segmented lung images using a possiblisitic fuzzy c means 
algorithm.41 They extended fuzzy c means clustering to better the handle noise found in medical 
images.  Their modification was to allow the distance measurement to be influenced by 
surrounding pixels. In the original fuzzy c means clustering, by Bezdek,42 pixels can have 
membership to multiple clusters. The pixels are randomly assigned to cluster and then iteratively 
assigned values to clusters until the change in cluster membership is below a threshold. When the 
algorithm converges the clusters are set.  
Gomathi and Thangaraj’s approach allows neighboring pixels, within a set window size, 
to influence the membership of a pixel. The authors found their approach helped compared to the 
original fuzzy c-means clustering algorithm when compared to manually segmented images.  
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 Hu et al. devised an automated lung segmentation method consisting of three steps.43 In 
the first step a threshold is applied to the grey level to find the region that is the lung. The second 
step divides the left and right lung. This step is accomplished by finding the anterior and 
posterior junctions using dynamic programming. In a graph with weights that are grey levels, the 
maximum cost path is the junction line. In the third step the boundaries are smoothed with 
morphological operations.  
The results were compared to the segmentations of two image analysts on eight subjects 
imaged three times. The difference in volume between the method and the image analysts was 
0.8 pixels root mean squared. The difference between subjects across the three scans had an 
average difference of 2.75% with a standard deviation of 2.29%. 
 Pu et al. proposed a method for lung segmentation designed to better account for 
juxtapleural nodules called adaptive border marching.44 The first step is to preprocess images by 
Gaussian smoothing, grey-level thresholding, and floodfilling to remove non-lung regions. After 
the preprocessing has finished an initial border is computed then adaptive border marching can 
start.  
Adaptive border marching consists of drawing lines around the border at a fixed length 
called a step. In this way, one step after another, the algorithm marches around the border 
reducing concavities due to the step length. In order to avoid oversegmentation, the step size is 
adaptive and decreases when concavity is greater than a threshold. When judged on 20 data sets 
this algorithm had an average oversegmentation of 0.43% and an average undersegmentation of 
1.63%.  
 Sun et al. proposed an algorithm for lung segmentation using a robust active shape 
approach.45 This approach consists of three steps. First, ribs are detected to aid in the placement 
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of the active shape model. Second, the active shape is placed. This shape is learned from a data 
set of previously segmented lungs. Third, the segmentation is optimized using a global optimal 
surface finding method that employs the maximum-flow algorithm. The segmentation algorithm 
was tested on 60 cases and had a Dice coefficient of 0.975 ± 0.006 and a mean absolute surface 
distance error of 0.84 ± 0.23mm.  
2.4 Classifiers 
2.4.1 Decision Trees 
A decision tree classifier has a tree structure and J48 is a Java implementation of 
Quinlan’s C4.5 release 8 decision tree classifier.46 This is an extension of Quinlan’s earlier work 
on decision trees.47 The leaves of the tree represent classes to which examples are assigned and 
the internal nodes, where the tree branches, are the decisions. Decisions are based on values of 
an attribute such as if a value is greater than x, take the left branch, otherwise take the right 
branch.  
To traverse the tree start at the root and follow each decision until you arrive at a leaf. 
These decisions can easily be turned into rules by making an “if” statement for every internal 
node’s test “anded” together and a “then” statement for the class of the leaves. The trick is to 
choose decisions for the internal nodes that make for a simple, yet accurate tree. Looking at the 
information gain or entropy can make a compact tree.  !"#$%&' &(, &*, … , &, = 	−&(log &( −&*log &* …	−&,log &, 
The pi’s are the percentage of examples assigned to each of n classes in the above 
equation.  Pruning of the tree can be achieved with the cost-complexity method from the 
Classification and Regression Trees (CART) learning system. Subtrees are pruned with the 
smallest increase in error relative to their size, cost-complexity pruning.48  
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Alternatively, reduced error pruning could be done on a separate training set, but that 
would reduce the amount of available data. Instead C4.5 uses a formula to project the expected 
error at a leaf/internal node from the observed error. In Weka’s implementation,49 a confidence 
limit, by default 0.25, is used to estimate the error and if the parent node has equal to or less error 
when removing its leaves then the tree is pruned. The minimum number of cases per leaf is 
usually set to two. 
To handle missing attributes there are a variety of approaches. The instance can be 
ignored; however this leads to a reduction in the available data. Another option is to treat missing 
attributes as their own value. A third option is to allow the example to partially go down several 
branches based on the likelihood for that feature.  
2.4.2 Random Forests 
Random Forests50 is an ensemble classifier comprised of decision trees whose class 
predictions are voted and the end result is the most popular class. The number of decision trees 
can be set as a parameter in Weka with each tree choosing the best feature from log 2 the total 
number of features chosen randomly, and bagging is used to select the training set. Bagging is a 
method that combines multiple classifiers by voting. These classifiers are trained on multiple 
versions of the data.51 
2.4.3 Naïve Bayes 
The Naïve Bayes classifier52 is a simple probabilistic method based on Bayes’ rule of 
conditional probability,48 which says that given a hypothesis H, and an event E that the 
probability (Pr) of H conditional on E is: 
Pr H E = 	PR E H Pr HPR[E]  
This formula is used to compute the posterior probability of each class for a case by normalizing 
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the output to one. For a two-class problem with H being the conditional probability of a class and 
output1 representing the value for class1 (output2 for class2), you can find class1’s probability as 
follows: 
PR class1 = 	 output1output1 + output2 
Then the class with the largest probability for that case is the prediction. There is an 
assumption that the features are independent, which is rarely the case. However, this classifier 
does reasonably well even when that assumption is broken. Missing values are easily handled by 
omitting that feature’s probability. If one attribute is zero in the training set, to help keep it from 
zeroing all the remaining attributes it is modified by a constant value, called the Laplace 
estimator, which can be added to both the numerator and the denominator. Weka’s 
implementation49 is based on the paper “Estimating Continuous Distributions in Bayesian 
Classifiers” by John et al..53 
2.4.4 RIPPER 
JRIP is a Java implementation of the RIPPER algorithm,54 repeated incremental pruning 
to produce error reduction. The algorithm is split into a build phase and an optimize phase. 
During the build phase rules are added greedily until the accuracy is perfect (or as near as 
possible) and then pruned. This process continues until all of the examples are covered, the 
description length is too large, or the error rate is too high.  
During the optimize stage, rules are again grown and pruned, with new rules grown from 
empty antecedents but also adding onto previous rules. If either of these has a shorter description 
length than the original rule then it replaces the original rule. Weka’s49 implementation of JRIP 
uses the default values of three folds, a minimum weight per instance of two, and two 
optimization runs.  
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2.4.5 Support Vector Machines (SVMs) 
Support vector machines can transform input data into a higher dimensional space. In this 
higher dimensional space it is typically easier to separate distinct classes from one another with a 
linear decision surface called a hyperplane. The hyperplane maximally separates the classes. The 
points on the border, which determine the hyperplane, are called support vectors, named by 
Cortes and Vapnik who invented the statistical learning theory upon which SVMs are based.30 
Finding the support vectors can be reduced to a quadratic optimization problem.  
Kramer et al. showed that support vector machines work on a variety of problems 
including the Letter, Page, Pendigit, Satimage, and Waveform data sets.55 A popular 
implementation is libSVM developed by Chang and Lin.56 It allows for errors, points on the 
wrong side of the hyperplane, which can be dealt with using a cost parameter. Different kernels 
can also be chosen to construct hyperplanes that are non-linear, such as a radial basis function or 
sigmoid kernel, which has a parameter gamma.  
The cost and gamma parameters can be found using a grid search, which is an exhaustive 
search on training data within a specified range. There is precedent for using SVMs on CT 
images. Dehmeshki et al.57 were able to apply support vector machines in the construction of 
Computer aided Detection (CAD) using thoracic CT images for automated nodule detection. 
WLSVM was the Weka interface used for libSVM.58 
2.5 Feature Selection 
When the number of features increases the performance of classifiers declines for 
decision trees.59 To reduce the number of features there are two methods that can be employed, 
besides embedded feature selection which is specific to a particular type of classifier. Filter 
feature selection is based on an assessment of the data, whereas wrapper feature selection uses a 
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machine learning method on a subset of the data.48 Below is a review of a couple of filter based 
feature selectors. 
2.5.1 Relief  
The Relief feature selector was proposed by Kira and Rendall.60 It performs feature 
ranking by choosing an instance at random and comparing the features to a random nearest 
neighbor. Near hits and near misses are used to update weights with the formula: WD = 	WD − diff xD, near-hitD * +	diff xD, near-missD * 
Kononenko61 extended Relief creating Relief-f.  The new version could now deal with 
noisy, incomplete, and multi-class data sets. For multi-class data sets the near misses were 
averaged from each different class. Robnik-Šikonja and Kononenko62 further extended Relief to 
handle regression. Regression is implemented not using the class, which is continuous for near 
misses, but instead using the relative distance between the predicted classes of two instances. As 
the distance increases the influence of other instances decreases exponentially.  
2.5.2 Correlation-based Feature Selection (CFS) 
The goal of Correlation-based Feature Selection63 is to find features that correlate to the 
class but are not correlated to each other. The feature subset evaluation function is  
MN = 	 O$PQO + O(O + 1)$QQ 
where MN  is the merit of subset S containing k features and $PQ  is the mean feature-class 
correlation and $QQ  is the average feature-feature inter-correlation. The Weka implementation 
discretizes attributes of nominal classes.  
2.5.3 Test –Retest 
In “Test-Retest Reproducibility Analysis of Lung CT Image Features” Balagurunathan et 
al. compared features from scans that were fifteen minutes apart.64 This analysis was designed to 
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find features that were stable and wouldn’t change from small differences between the two scans. 
The tumors were segmented both manually by a radiologist and with a single click region 
growing ensemble approach. Features were reported that met a concordance correlation 
coefficient cutoff of 0.85, 0.90, and 0.95. 
2.6 Metrics  
Accuracy, or success rate, is the number of correct examples (true positives and true 
negatives) over the total.49 It is the percent correct. It is a point on the receiver operating 
characteristic (ROC) curve. ROC curves plot the false positive rate on the x-axis and the true 
positive rate on the y-axis for, generally, the smallest class. This shows the trade offs between 
false positives and true positives. The AUC or area under the receiver operating characteristic 
curve reduces this plot to a single measure. It is problematic for evaluating machine learning 
models, as one model might outperform another at a given point on the curve. However, it is 
popular in the medical literature. The Wilcoxon signed-rank test measures if two populations 
have the same mean.65 Pairs are ranked ordered and then their difference is compared.  The null 
hypothesis is more likely if the difference is close to zero. True positive, TP, is the number of 
cases that were predicted positive and are actually positive. True negative, TN, is the number of 
cases predicted negative that are actually negative. False positive, FP, is the number whose 
prediction is positive but the case is negative. False negative, FN, is when the prediction is 
negative but the case was positive. An F-measure 48 is  2 ∗ 	UV2 ∗ UV + WV + WX 
Sensitivity is the number of people with a positive test result, who are in the true positives. 
Specificity is the proportion of people without a disease who have a negative result, 1-false 
positive.  
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 A dice coefficient can be used to measure how well a segmentation compares to another 
segmentation. Originally developed by Lee Dice to compare the degree two different species 
overlap in ecological studies, the dice coefficient has been adapted for comparing the overlap of 
pixels in two segmentations. If Y is the number of pixels of segmentation A and Z is the number 
of pixels of segmentation B and ℎ is the number of pixels in the intersection of Y and Z then the 
amount of association is  2ℎY + Z 
While the dice coefficient is useful for comparing two segmentations there is no ground truth for 
lung nodule segmentations. A radiologist’s segmentation can be used or the intersection of 
segmentations by multiple radiologists, but there is no absolute answer at the pixel level as to 
what should and should not be segmented.   
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CHAPTER 3: METHODS1 
 
3.1 Data Sets 
In this section, we discuss the data sets as well as the methods of image pre-
preprocessing, segmentation, and feature extraction. Descriptions of the features are also given. 
The workflow we used to develop predictive models is represented in Figure 3.1 and is based on 
work by Kumar et al..14  
3.1.1 Survival Prediction Data Set 
The data set used for predicting survival consisted of de-identified CT-scan images from 
the Moffitt Cancer Center, Tampa. The images are in the DICOM (Digital Imaging and 
Communications in Medicine) format. The data set consists of patients with tumor types of 
Adenocarcinoma and Squamous-cell Carcinoma. This dissertation focuses on the 
adenocarcinoma patients. CT-scans of 81 adenocarcinoma patients were used for survival time 
analysis. The slice thickness of the acquired CT-images ranged from 2.5mm to 6mm with an 
average thickness of 4.75mm. There were 32 cases in stage one, 20 in stage two, 25 in stage 
three, and 4 cases in stage four. The mean survival time was 879 days.  
The adenocarcinoma cases were divided into the upper and lower quartiles of survival. 
The lower quartile consisted of 20 cases surviving from 103 to 498 days with an average survival 
of 288 days. The upper quartile consisted of 20 cases surviving from 1351 to 2163 days with an 
																																																								1A version of these methods was previously published in two papers.  
Hawkins SH, Korecki JN, Balagurunathan Y, et al. Predicting Outcomes of Nonsmall Cell Lung Cancer Using CT 
Image Features. IEEE Access. 2014;2:1418-1426.	
Hawkins S, Wang H, Liu Y, et al. Predicting Malignant Nodules from Screening CT Scans. Journal of Thoracic 
Oncology. 2016;11(12):2120-2128. See Appendix A for permissions. 
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average survival of 1569 days. These two classes were chosen in the expectation that their image 
features would be the easiest to differentiate, provide some information on the possibilities, and 
the training set is balanced.  
The class distribution of survival time is as follows:  
• patients with a survival time in the highest quartile [Class1] = 20  
• patients with a survival time in the lowest quartile [Class – 1] = 20.  
3.1.2 NLST Study Population for Malignancy Prediction 
Data and images from the NLST were accessed through the NCI Cancer Data Access 
System.66 The study design and main findings of the NLST have been described well.11 Briefly, 
53,454 current or former smokers between 55 and 74 years of age were enrolled at 33 U.S 
medical centers.  
The participants were randomly assigned to the LDCT-arm (26,722 subjects) or CXR-
arm and asked to undergo a baseline and two annual follow-up screenings. CT images were 
downloaded and a trained radiologist (H.W.) identified the nodules of interest and ensured 
correct matching across annual scans.  
3.1.2.1 Patients with SDLC and Nodule-Positive/Cancer-Free Participants  
As described in Schabath et al.,10 we restructured the entire CT arm of the NLST 
according to screening histories. Based on the NLST protocol, a positive screen was defined as 
non-calcified nodule ≥ 4 mm in the axial plane or, less commonly, other abnormalities such as 
adenopathy or pleural effusion. Six different screen-detected lung cancer patient cohorts were 
defined based on specific sequences of screening results.  
For this analysis, we focused on two screen-detected lung cancer (SDLC) patient cohorts 
described in Figure 3.2. Both patient groups had baseline (T0) positive screens not associated 
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with a lung cancer diagnosis. Individuals in the SDLC Cohort 1 had a screen-detected lung 
cancer at the first follow-up screen (T1); SDLC 2 had positive screens at T0 and T1 and a screen-
detected lung cancer at the second follow-up screen (T2), which was approximately two years 
after the baseline screen. Complications with segmentation as described in Table 3.1 led to there 
being 85 patients each in SDLC1 and SDLC2. 
To compare incidence lung cancer cases to cancer-free (controls) screening participants, 
we identified two cancer-free cohorts with benign pulmonary nodules [bPN] that were frequency 
matched 2:1 to the SDLCs on demographic characteristics and risk factors (i.e., age [± 5 years], 
sex, smoking status, and pack-years smoked [± 5 pack-years]). bPN cohorts -1 and -2 contained 
208 and 184 subjects, respectively. Of these, 176 nodules from bPN Cohort 1 and 152 nodules 
from bPN Cohort 2 were successfully segmented and hence, available for subsequent radiomic 
feature extraction. 
Segmentation complications include calcification, or the nodule being attached to the 
pleural wall (Table 3.1). Some of these challenges with spiculation and semi-solid nodules can 
be overcome when better segmentation algorithms are developed. This nested, matched study 
design minimizes the influence of confounders and risk factors between lung cancer patients and 
bPN subjects.  
Full demographic and clinical descriptors of these cohorts are provided in Table 3.2. The 
NLST database-specific patient I.D.’s are provided in Supplemental Table B.1. At baseline, there 
was a trend to larger size in the cohort that eventually presented with cancer. The average + SD 
of the longest diameters were:  8.06 + 3.45 mm for bPN1 and 8.6 + 3.85 mm for bPN2, and 
12.07 + 5.35 mm for SDLC1 and 12.086 + 9.89 for SDLC2. Although these differences were 
significant, the multivariate approach increased predictive accuracy. 
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3.2 Image Pre-processing  
The initial CT segmentation, separating the lung region from the rest of the body, was 
done using the algorithm provided in the Lung Tumor Analysis (LuTA) software suite of 
Definiens.67 On completion of the lung field segmentation, tumor identification was manually 
conducted by one of the radiologists at the H. Lee Moffitt Cancer Center or another person with 
expertise in identifying lung tumors. Upon identification, the tumor was segmented out using the 
region-growing algorithm developed by Gu et al.39 An expert provided the initial seed point for 
the algorithm. The algorithm finds the tumor boundary across the image sequences. This 
boundary contains the tumor objects in each slice of the CT-image sequence. Figure 3.3(a) shows 
the initial CT image, Figure 3.3(b) shows the segmentation of the lungs, and Figure 3.3(c) shows 
the tumor segmentation after region growing.  
3.3 Image Feature Extraction and Feature List 
In a previous study by Basu et al.,68 a large set of 2D and 3D image features were 
evaluated for their effectiveness in building a classifier model to distinguish between 
Adenocarcinoma and Squamous-cell Carcinoma. The study concluded that there was no clear 
advantage in accuracy between 2D and 3D features, but 3D features simplified constructing 
classifiers. Thus for this study, only 3D image features were considered. The image feature 
extraction algorithms were written in C++ and the executables were embedded into the LuTA 
software. The image feature extraction was done on only the tumor objects after segmentation by 
seed growing. The features were normalized from −1 to 1. The major feature types described in 
the paper by Balagurunathan et al.69 we evaluated are as follows:  
• Texture features: 125 Laws Features from five one-dimensional kernels, 30 wavelet 
features using Daubechies (Coiflet) wavelets calculating energy and entropy.  
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• Geometric features: 13 size and volume descriptions in pixels and millimeters or 
centimeters including longest diameter. 12 shape features including compactness, 
elliptical fit asymmetry, and density, 14 location features measuring attachment and 
distance to the pleural wall.  
• Intensity based features: 8 features of brightness measure statistics in terms of 
Hounsfield units (HU), 11 run-length features measuring contiguous grey levels in a 
direction, and 6 co-occurrence matrices including contrast, energy, homogeneity, 
entropy, mean, and maximum probability. A complete list can be found in 
Supplemental Table B.2.  
3.3.1 Target Lung Nodule Identification for Malignancy Prediction 
Two radiologists reviewed all CT images at both the lung window setting (width, 1500 
HU; level, -600 HU) and mediastinal window setting (width, 350 HU; level, 40 HU). The 
identification of cancerous nodules in SDLC cohorts was based on the tables provided by the 
NLST with information about the location, size, and histology for those that were resected.  
Nodule location wasn’t always available for bPN cohorts. In these cases, the head 
radiologist, Ying Liu, identified the suspicious 4-12 mm diameter IPN using prior experience. 
For those cases with multiple lung nodules, any nodule with diameter of more than 4 mm in a 
lung window setting was identified. The largest nodule at time 0 was used for feature extraction 
and followed through time. Patients diagnosed with cancer at T1 or T2 were placed into separate 
cohorts based on their screening history (Figure 3.2) and their baseline T0 scans were analyzed. 
Table 3.3, shows 270 prevalent cases of cancer at the first screen, and 196 SDLCs were 
identified following a prior positive scan, compared to 125 SDLCs following nodule-negative 
screens, and 44 interval cases diagnosed incidentally before the next screening.10 
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3.3.2 Segmentation 
Slice numbers of cancerous nodules were provided by NLST and reviewed by 
radiologists, Ying Liu and Qian Li, who provided additional anatomical locations for use during 
segmentation. Nodules were segmented in 3D with our single-click ensemble segmentation 
approach,39 running on a LuTA platform (Definiens, Munich Germany). NLST provided up to 
three reconstructions for each time point. The reconstruction chosen by scanner type is found in 
Table 3.4. Using an automated segmentation algorithm reduces intra-observer variations; 
however relying on a radiologist to find the nodules means there is inter-observer variation. 
3.3.3 Features 
There were 219 3-D image features extracted from the baseline scan. A challenge for 
high-dimensional feature data is over-fitting by having too many features and too few subjects. 
Hence, there is a need to prioritize features that: 1) aren’t redundant, 2) have a large inter-subject 
biological range, and 3) are stable. In prior work, we studied stability of quantitative features 
under repeated (“coffee break”) scans and found some of the stable features are prognostic and 
predictive.64,69 The features are listed in Supplemental Table B.3. 
3.3.4 Classifier Modeling 
WEKA49 was used to build and test classifiers. We compared J48, JRIP, Naïve Bayes, 
support vector machines (SVM), and Random Forest(s). J48 is a decision tree classifier.46 The 
decision tree was pruned to make it smaller and more generalizable. The confidence factor for 
pruning the decision tree was set to 0.25 and the minimum number of cases per leaf was set to 2. 
JRIP is a rule learner.54  
We used 3 folds, a minimum weight for instances in a rule set to 2.0, 2 optimization runs 
and a seed of 1 for splitting data into growing and pruning sets.  Naïve Bayes53 is a probabilistic 
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classifier. The classifier labeled Naïve Bayes53 in Weka49 was used for this work. Support vector 
machines30 project the data into a multi-dimensional space to separate classes with a hyper plane. 
We used libSVM as our implementation of support vector machines.56 Both linear and radial 
basis function kernels were used in building a support vector machine. Cost and gamma 
parameters were tuned on training data with a grid search.  
The random forests classifier is an ensemble classifier that produces multiple decision 
trees. The number of decision trees used was 200.70 Each node in the tree used the best feature of 
log 2 the total number of features chosen randomly. When doing cross validation experiments, 
two filter feature selection methods were run per fold before classification: Relief-f60-62 and 
correlation-based feature subset selection (CFS)63. Relief-f used a ranker search method. CFS 
used a greedy stepwise search method.  
3.4 Feature Subsets 
Computed image features can have a high correlation with each other. This property 
combined with the fact that the number of features available to us was much greater than the 
number of examples, required the investigation of feature selection techniques to improve 
classification accuracy.  
Feature selection was done per fold during training. Leave-one-out cross validation 
(LOO) was conducted on the data for survival prediction. For malignancy prediction 10-fold 
cross validation and as well as separate training and testing sets were used. In addition to feature 
selection, some of the classifiers’ models do implicit feature selection. For instance, the decision 
tree and rule based classifiers subselect features. Also, support vector machines weight features. 
However, Naïve Bayes uses all provided features for classification of the test set. All of 
classifiers explore all of the features to build models on the training set.  
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3.4.1 All Features 
This group includes all 219-image features. No feature selection was performed, thus 
providing a baseline for the effectiveness of the feature selection techniques.  
3.4.2 Relief-f 
The Relief-F algorithm60-62 is a feature evaluator that compares an instance’s feature 
value to the nearest neighbor of both the same and opposite classes. We used a seed of 1, 10 
nearest neighbors, and a ranker search. In this work, Relief-F was used to assign ranks to each 
individual feature. We used the top five and ten features found by the algorithm. Table 3.5 shows 
the top features when predicting survival. The top ranked features measure tumor attachment to 
the wall of the lung.  
3.4.3 Correlation Based Feature Selection 
Correlation based Feature Selection (CFS) searches for features that correlate to a class 
but do not correlate with each other. The implementation used was found in WEKA49 and 
utilized local prediction. We used a greedy stepwise forward search, which generated rankings. 
CFS discretizes attributes for nominal classes.  
The features chosen are shown in Table 3.6. We can see that CFS prefers texture features 
with a few shape features when compared to the choices of Relief-F. Relief-F focuses on pleural 
wall attachment type features.  
3.4.4 Test-retest 
Test-retest features were determined by comparing the stability of features generated 
after two different scans of the same patient fifteen minutes apart.69 If a feature is repeatable then 
the two subsequent scans should yield a similar value. The tumor was segmented both manually 
by a radiologist and with a single click ensemble approach. Different thresholds of correlation 
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were used. Attributes were kept that had a test-retest correlation measured by a concordance 
correlation coefficient (CCC) of above 0.85, 0.90, and 0.95.  
At each correlation threshold different attributes were found using the manual and 
ensemble segmentation methods as well as the intersection of both. The 23 features found to be 
stable at a CCC of 0.95 for both manual and ensemble segmentations on the RIDER data set are 
shown in Supplemental Table B.3. The 37 features found to be stable at a CCC of 0.95 for both 
manual and ensemble segmentations on the NLST data set Cohort 1 time 0 are shown in 
Supplemental Table B.4. 
3.5 Chapter 3 Tables and Figures 
 
Table 3.1: Common segmentation complications. 
Complication Description 
Nodule attached to lung wall Often the lung field preprocessing will identify any nodules 
attached to the lung wall as body tissue 
GGO Ground glass opacity nodules will segment incorrectly 
depending on the intensity of the surrounding tissue. In 
some cases the “click and grow” will yield no results.  
(Error Message: Area too Dark) 
Semisolid Nodules When selecting a seed point in tissue composed of varied 
intensities (GGO + Solid) Definiens segmentation software 
will sometimes select the entire area of interest while other 
times only selecting the solids, leaving out the GGO 
Inflammation / Scar tissue When selecting a GGO the “click and grow” will lock onto 
nearby inflammation with brighter intensity. When selecting 
a solid nodule the “click and grow” will lock onto nearby 
scar tissue with brighter intensity. 
Contains air If a larger nodule has a dark center the “click and grow” 
routine will try to segment it out but the result is usually 
quite incorrect; removing tissue that should be included. 
Spiculation Generally the more highly spiculated nodules will present 
more difficulty, and will have a greater chance of having 
nearby bronchi included  
Between two lobes A nodule can sometimes attach itself to a fissure line 
between two lobes, allowing it to “move” more than nodules 
normally do when scrolling through a series. 
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Table 3.1 (Continued) 
Bronchial Tree If the bronchial tree is anywhere near the tumor nodule it 
 is almost always included when growing the ROI 
“Independent” nodules too close Two independent nodules at T0 can intersect later at T2 
 and be mostly impossible to differentiate. 
Bone/ Calcification If nodule contains a calcification or is near a bone and  
that tissue is included, the features can be highly skewed 
 by even a pixel or two. 
 
Table 3.2: Demographics and clinical characteristics of NLST cohort cases. 
Characteristic 
Lung Cancer 
Cases 
 (N = 170) 
Nodule-Positive 
Controls (N = 328) P-value
1  
     
Age, mean (SD) 63.7 (5.11) 63.5 (5.1) 0.66  
Sex, N (%)      
 Male 94 (55.3) 192 (58.5)   
 Female 76 (44.7) 136 (41.5) 0.28  
     
Race, N (%)     
 White 161 (94.7) 315 (96.0)   
 Black, Asian, Other 9 (5.3) 13 (4.0) 0.49  
     
Ethnicity, N (%)     
 Hispanic or Latino 0 (0.0) 2 (0.6)   
 Neither Hispanic/Latino and 
Unknown 
170 (100.0) 326 (99.4) 0.55  
      
Smoking, N (%)     
 Current 89 (53.4) 175 (53.4)   
 Former 81 (47.6) 153 (46.6) 0.85  
     
Pack-Years Smoked, mean (SD)     
 Current smokers 63.2 (25.8) 62.0 (21.3) 0.69  
 Former smokers 64.5 (27.6) 63.7 (26.8) 0.83  
     
Self-Reported History of COPD, N 
(%) 
    
 Yes 13 (7.6) 19 (5.8)   
 No 157 (92.4) 309 (94.2) 0.44  
     
FH of Lung Cancer, N (%)     
 Yes 41 (24.1) 56 (17.1)   
 No 129 (75.9) 272 (82.9) 0.07  
     
Stage, N (%)     
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Table 3.2 (Continued) 
 I 117 (68.8) --   
 II 12 (7.1) --   
 III 21 (12.3) --   
 IV 18 (10.6) --   
 Carcinoid, Unknown 2 (1.2) -- --  
      
 Histology, N (%)     
 Adenocarcinoma 108 (63.5) --   
 Squamous cell carcinoma 38 (22.4) --   
 Other, NOS, Unknown 24 (14.1) -- --  
Abbreviations: COPD = chronic obstructive pulmonary disease; FH = Family history;  
1 P-values calculated using Fisher’s exact test for categorical variables, Student’s t-test for 
continuous variables 
 
Table 3.3: NLST cancer-diagnosed cohorts description. 
Cohort Number Patients Cancer Diagnosed: 
Prevalent 270 At first screen 
T0 Interval 18 Following 1 negative screen, prior to 2nd screen 
T1 Interval 10 Following 2 negative screens, prior to 3rd screen 
T2 Interval 16 Following 3 negative screens 
Screen-detected 1 104 At 2nd screen following 1 nodule-positive screen 
Screen-detected 2 92 At 3rd screen following 2 nodule-positive screens 
Screen-detected 3 62 At 2nd screen following 1 negative screen 
Screen-detected 4 63 At 3rd screen following 2 negative screens 
 
Table 3.4: Scanner type and reconstruction kernels. 
GE Standard Lung/Bone 
SIEMENS B30f B50f 
PHILIPS C D 
TOSHIBA-CHOICE 1 FC01 FC30 
TOSHIBA-CHOICE 2 FC10 FC51 
 
Table 3.5: Features chosen to predict survival by Relief-f feature selection from all of the 
available features in a leave one out cross validation. Count is how many times the feature was 
chosen with the maximum being 40, which is once in every fold. Feature name identifies the 
feature.69 
Feature Selection Count Feature Name 
Top 5 Relief-f 40 X8d_3D_Ratio_Free_To_Attached 
Top 5 Relief-f 40 X8a_3D_Is_Attached_To_Pleural_Wall 
Top 5 Relief-f 40 X8c_3D_Relative_Border_To_PleuralWall 
Top 5 Relief-f 40 X8b_3D_Relative_Border_To_Lung 
Top 5 Relief-f 40 X3D.Wavelet.decomposition...P1.L2.C14.Layer.1 
Top 10 Relief-f 40 X8d_3D_Ratio_Free_To_Attached 
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Table 3.5 (Continued) 
Top 10 Relief-f 40 X8a_3D_Is_Attached_To_Pleural_Wall 
Top 10 Relief-f 40 X8c_3D_Relative_Border_To_PleuralWall 
Top 10 Relief-f 40 X8b_3D_Relative_Border_To_Lung 
Top 10 Relief-f 40 X3D.Wavelet.decomposition...P1.L2.C14.Layer.1 
Top 10 Relief-f 40 X3D.Wavelet.decomposition...P1.L2.C10.Layer.1 
Top 10 Relief-f 39 X3D.Laws.features..E5.S5.R5.Layer.1 
Top 10 Relief-f 31 X3D.Laws.features..W5.W5.L5.Layer.1 
Top 10 Relief-f 21 X3D.Laws.features..L5.S5.W5.Layer.1 
Top 10 Relief-f 5 X3D.Wavelet.decomposition...P1.L2.C9.Layer.1 
Top 10 Relief-f 13 avgLRE 
Top 10 Relief-f 11 avgSRE 
Top 10 Relief-f 7 X3D.Laws.features..L5.L5.S5.Layer.1 
Top 10 Relief-f 8 X3D.Laws.features..W5.E5.L5.Layer.1 
Top 10 Relief-f 2 X3D.Laws.features..S5.S5.E5.Layer.1 
Top 10 Relief-f 2 X3D.Laws.features..W5.S5.L5.Layer.1 
Top 10 Relief-f 2 X3D.Wavelet.decomposition...P1.L2.C11.Layer.1 
Top 10 Relief-f 4 X3D.Laws.features..S5.S5.W5.Layer.1 
Top 10 Relief-f 8 X3D.Laws.features..S5.L5.E5.Layer.1 
Top 10 Relief-f 3 X5a_3D_MacSpic_NumberOf 
Top 10 Relief-f 2 Histogram.ENERGY.Layer.1 
Top 10 Relief-f 1 X3D.Laws.features..R5.E5.L5.Layer.1 
Top 10 Relief-f 1 X3D.Laws.features..E5.S5.W5.Layer.1 
 
Table 3.6: Features chosen to predict survival by CFS feature selection from all of the available 
features in a leave one out cross validation. Count is how many times the feature was chosen 
with the maximum being 40, which is once in every fold. Feature name identifies the feature.69 
Feature Selection Count Feature Name 
Top 5 CFS 40 X3D.Laws.features..W5.S5.R5.Layer.1 
Top 5 CFS 40  X3D.Laws.features..W5.S5.W5.Layer.1 
Top 5 CFS 13 X3D.Laws.features..R5.S5.S5.Layer.1 
Top 5 CFS 13 X3D.Laws.features..S5.S5.W5.Layer.1 
Top 5 CFS 14 X3D.Laws.features..W5.S5.S5.Layer.1 
Top 5 CFS 28 Longest.Diameter..mm. 
Top 5 CFS 26 Short.Axis...Longest.Diameter..mm.. 
Top 5 CFS 24 Short.Axis..mm. 
Top 5 CFS 1 X3D.Laws.features..S5.S5.R5.Layer.1 
Top 5 CFS 1 X3D.Wavelet.decomposition...P1.L2.C4.Layer.1 
Top 10 CFS 40 X3D.Laws.features..W5.S5.R5.Layer.1 
Top 10 CFS 40 X3D.Laws.features..W5.S5.W5.Layer.1 
Top 10 CFS 13 X3D.Laws.features..R5.S5.S5.Layer.1 
Top 10 CFS 13 X3D.Laws.features..S5.S5.W5.Layer.1 
Top 10 CFS 14 X3D.Laws.features..W5.S5.S5.Layer.1 
Top 10 CFS 40 Longest.Diameter..mm. 
Top 10 CFS 40 Short.Axis...Longest.Diameter..mm.. 
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Table 3.6 (Continued) 
Top 10 CFS 40 Short.Axis..mm. 
Top 10 CFS 40 Mean..HU. 
Top 10 CFS 40 StdDev..HU. 
Top 10 CFS 28 Volume..cm.. 
Top 10 CFS 26 X5a_3D_MacSpic_NumberOf 
Top 10 CFS 24 X8a_3D_Is_Attached_To_Pleural_Wall 
Top 10 CFS 1 X3D.Laws.features..S5.S5.R5.Layer.1 
Top 10 CFS 1 X3D.Wavelet.decomposition...P1.L2.C4.Layer.1 
 
 
Figure 3.1: Schematic representation of the workflow involved in preparing data for predictive 
models. For training all the labeled data is provided and a model built.  For testing, the figure 
above serves. 
 
 
Figure 3.2: Flowchart of cohorts. Both cohorts 1 and Cohort 2 had a nodule-positive/cancer-
negative screen at time 0 (T0). Cohort 1 had a nodule-positive screen at time 1 (T1), with a 
screen-detected lung cancer diagnosed in 104 of the cohort members. These individuals were 
demographically matched to subjects with benign pulmonary nodules (bPNs) and the same 
screening history. Of the 208 bPNs identified at T1, 176 were successfully segmented. Cohort 2 
had a nodule-positive/cancer-negative screen at T1, followed by a nodule-positive screen at time 
2 (T2), with 92 cohort members having screen-detected lung cancer. These individuals were 
demographically matched to 184 subjects with bPNs, 152 of which were successfully segmented. 
Segmentation errors are presented in Table 3.1. 
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Figure 3.3: Sample CT-image slice. (a) Initial CT image. (b) Lung segmentation. (c) Tumor 
segmentation.  
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CHAPTER 4: RESULTS AND CONCLUSIONS2 
 
4.1 Predicting Survival Results 
Table 4.1 represents the results with the best accuracy and area under the receiver 
operating curve from a leave- one-out analysis using each classifier. With 40 examples, leave-
one-out cross validation is performed by using each subset of 39 examples to do feature selection 
and build a model using the specified classifier, which is tested on the single held out example. 
Finally, the accuracy on each held out example is averaged to find the final leave-one-out 
accuracy. The highest classification accuracy was 77.5% and was obtained with the decision tree 
classifier using the top 5 features found by Relief-f.  
The confusion matrix for this result can be found in Table 4.2. The highest AUC was 
with 10 features, chosen by Relief-f at 0.732 for decision trees. For both rule learners and the 
decision trees there were often few points on the curve. All feature selection was done per fold. 
CFS had an occasional failure selecting test-retest features and those results are omitted. Also, 
results that are below 60% accuracy are not listed in Tables 4.3-4.6.  
Tables 4.3-4.6 show the results of doing feature selection on the ‘‘stable and 
informative’’ features from test-retest for the classifiers used here. In these tables we see that 
while the features selected in the test-retest data sets can be subselected to provide good 
classifiers, they did not result in the most accurate ones. The data set they come from was more 
																																																								2	A version of these results was previously published in two papers.  
Hawkins SH, Korecki JN, Balagurunathan Y, et al. Predicting Outcomes of Nonsmall Cell Lung Cancer Using CT 
Image Features. IEEE Access. 2014;2:1418-1426.	
Hawkins S, Wang H, Liu Y, et al. Predicting Malignant Nodules from Screening CT Scans. Journal of Thoracic 
Oncology. 2016;11(12):2120-2128. See Appendix A for permissions.	
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homogenous in scanner type and parameters. Our data set has a different field of view for every 
patient and different slice thicknesses, as well as different scanners.  
 Figure 4.1 shows the Kaplan-Meier curve of the survival of the two predicted classes 
using our best classifier, a decision tree with five features selected using Relief-f. With a p of 
0.0219 we reject the null hypothesis that the groups are the same. Thus, the predicted classes are 
distinct from one another when predicting survival groups. Table 4.7 shows the results when 
training with only volume as a feature. This feature can be useful for differentiating benign from 
malignant nodules. Here, its accuracy is too low to be useful.  
4.2 Predicting Survival – Conclusions 
This is the first study we know of to examine the use of image features from CT scans at 
the time of diagnosis to predict survival time on a heterogeneous data set. The accuracy of 77.5% 
is promising and is the highest known accuracy for this problem. This result, using five features 
chosen with Relief-f, was well above what we were able to achieve using volume alone, which 
had an accuracy of 45%. The image features from the CT scans may represent phenotypes 
capable of allowing more accurate predictions than can be made by human analysis alone. The 
variability of the imaging parameters is a major concern when developing predictive models 
using, predominantly, image features. If the same field of view and slice thickness were used for 
all cases, then precision could increase. Clearly, future work requires new stable image features 
and perhaps an approach using an ensemble of classifiers in which different subsets of features 
may further improve the accuracy of survival prediction.  
4.3 Predicting Malignancy Results 
We test the hypothesis that radiomic analyses of screening CTs at baseline can accurately 
predict which IPNs will subsequently develop into clinical cancers. The workflow of our study is 
	41 
presented in Figure 4.2. According to NCCN71 and ACR13 guidelines, the method of choice to 
distinguish cancerous from benign nodules is to measure nodule growth following a subsequent 
screening session after 7-12 months: those with significant growth, 1.5mm or greater13, are 
classified as cancerous. Figure 4.3 presents two nodules at baseline and after a subsequent 1-year 
follow-up screen. Notably, there was nothing obvious to distinguish the benign (upper) from 
cancerous (lower) IPNs at baseline. Hence, they were both characterized as IPNs in the T0 
baseline screen. The radiomics features show a few of the most divergent measures, including 
relative volume of air spaces and mean attenuation. Notably, baseline volume was larger in the 
benign nodule in this case.  
4.3.1 Feature Stability 
We prioritized a set of features from the RIDER data set, which consisted of two non-
enhanced CT scans of the same patients taken 15 minutes apart with the same scanner settings. 
From these analyses, 23 features (Table 4.8) exhibited a concordance correlation coefficient 
(CCC) of > 0.95.64,69 The most stable feature category contained nodule size descriptors, where 
84% of the features showed concordance > 0.95. Texture features demonstrated lower levels of 
concordance due to their high dependence on the CT attenuations. Scanner parameter settings 
such as field of view, which affects pixel size, also affect textures.  
A histogram of the pixel sizes for each of our cohorts is provided in Figure 4.4, showing 
that there was a large amount of variability in the data sets. While such variability may not 
adversely affect a radiologists’ ability to provide qualitative assessment, it will likely affect the 
ability to extract quantitative radiomic data.  
Further, although the protocol specified a slice thickness of 2.0 mm, it can be seen in 
Figure 4.5 that the majority were 2.5 mm and above, which also may impact the extraction of 
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radiomic data. Non-standardized acquisitions are one known limitation in large multi-center 
trials like the NLST. In radiomics, all these variations add to feature description noise and 
influence prediction accuracy. Re-interpolation of the data to a fixed voxel size is possible, but 
generates noise that cannot be compensated1.  
4.3.2 Classifier Models 
As presented in Table 4.9 the best accuracy for predicting development of cancer one 
year hence (at T1) using baseline scans was 80.1% (AUC = 0.83; FPR = 9%) using a random 
forests classifier with RIDER prioritized features.72 We used the Wilcoxon signed-rank test73 on 
the results of thirty 10-fold cross validations using the best volume classifier and best all feature 
classifier.  
Significance was found at the 0.01 level for our full feature approach with the top 
classifiers compared to volume for both accuracy and AUC. However, we did try other tests such 
as the 5x2 fold cross validation followed by an F-test,74  finding significance at the 0.05 level for 
only a subset of random seeds. We believe with more data our approach will always be 
statistically significantly better than volume. Table 4.10 shows full results for Cohort 1. For 
Cohort 2 the best feature selection/classifier pair shows a top accuracy of 78.7% (AUC = 0.75; 
FPR = 11%) for predicting development of cancer 2 years hence (at T2). This accuracy was 
achieved with support vector machines using a radial basis function kernel with RIDER-
prioritized features and feature selection with Relief-f to find the 10 best features. Using 
Wilcoxon’s signed-rank test73 on 30 10-fold cross validations showed this result to be better than 
volume, which had an accuracy of 71.4%, at the 0.01 level. Full results for Cohort 2 are in Table 
4.11. It is understandable that a prediction further into the future in Cohort 2 is not as accurate as 
Cohort 1. 
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An alternative approach to cross validation is to use one cohort for training and the other 
for testing. Table 4.12 shows the accuracy when training on SDLC and bPN T1 cohorts and 
testing on SDLC and bPN T2 cohorts. In this case, the best features were RIDER prioritized 
further sub-selected with Relief-f. These features were then used to build a random forests 
classifier and the classifier was applied to the previously unseen Cohort 2, which yielded a top 
accuracy of 76.79% (AUC = 0.81; FPR = 18%). This relatively reduced accuracy is expected 
because the biology’s of cancers presenting 1 or 2 years hence are likely different. Using 
bagging51 to generate 30 training sets a Wilcoxon test73 showed significance over using volume 
alone with the top classifiers for AUC at the 0.01 level. With volume alone, using a JRIP 
classifier yielded an accuracy of 72.15%. Full results are presented in Table 4.12. 
4.3.3 Solidity  
There were 58 nodules that were ground glass in appearance, 41 nodules that were semi-
solid, and 338 that were solid. Some nodules could not be scored. For a full break down see 
Table 4.13. Across cohorts, 24 ground glass nodules became cancerous, 27 semi-solid nodules 
became cancerous, and 85 solid nodules became cancerous. One of the limitations of this study is 
that the 97 nodules that were not solid may take longer than the study period to present as cancer. 
Kobayashi and Mitsudomi found that 20% of ground glass lung nodules and 40% of semi-solid 
nodules grow slowly while others remain unchanged for years.75  
4.3.4 Risk Score 
The Lung Imaging Reporting and Data System (Lung-RADS) was developed by the 
American College of Radiology to standardize the screening of CT lung cancer images13 into 
categories from benign to cancer. We performed Lung-RADS categorization on T0 images from 
58 pre-cancers and 127 benign nodules from SDLC-2 and bPN-2, respectively. Categories 3 and 
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below were labeled as benign and categories 4A and 4B as malignant. The accuracy of lung-
RADS in predicting the subsequent development of cancer was 71.4% (Table 4.14). Another risk 
score by McWilliams et al. (Brock University cancer prediction equation) utilizes age, sex, 
family history of cancer, presence of visually detected emphysema, nodule size, solidity, nodule 
location, number of nodules, and spiculation to generate a probability of cancer.20 In the 
McWilliams et al. model, 5% risk is a low probability of developing cancer, intermediate is a 5% 
to 10% risk, and high is greater than 10%. 
We applied this model to the same Cohort 2 data that were scored for Lung-RADS. We 
labeled the first two groups as non-cancer and greater than 10% as cancer. The accuracy of this 
model was 78.9% (Table 4.14). To extend our radiomics model, we generated a risk score by 
categorizing individuals based on their probability of belonging to the malignant or benign 
group. In our case, we separated low, intermediate low, intermediate high and high risk as 
quartiles. The results using a random forests classifier on the same data set are shown in Table 
4.14.  
As shown, the radiomics approach performed very well for extreme phenotypes, with 
accuracies of 92% and 93% for predicting high and low risk, respectively. Although results in 
the intermediate groups were more equivocal, at 63-68%, the overall accuracy of automatically 
extracted features was 80.0%, compared to McWilliams, 78.9%, and Lung-RADS 71.4%. We 
also compared the radiomics approach to using volume as the only feature, which had an 
accuracy of 71.8%. Using McNemar’s test,76 the radiomics result is significantly better than 
Lung-RADS, two-tailed p=0.0177, and better than classification with the same models using 
volume as the only feature, two-tailed p=0.025, but not significantly better than McWilliams, 
two-tailed p=0.8383. However, the radiomics model has the added benefit to radiologists of 
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being automated after the nodule has been found for segmentation for a given nodule. Figure 4.6 
shows the ROC curves for the McWilliams approach, which has an AUC of 0.67, volume, which 
has an AUC of 0.74, and the radiomics scoring schema, which has an AUC of 0.87.  
4.4 Predicting Malignancy Discussion  
The long-term vision for this work is to qualify the application of radiomic biomarkers to 
reduce over-diagnosis and over-treatment of screen- and incidentally-detected lung nodules. It 
can be envisioned that these radiomics risk scores can be used now to prescribe optimal time for 
follow up scans for definitive differential diagnosis. Hence, a subject with a low risk score could 
be scanned less often than one with a high score. The current results show that a subset of 
radiomic features extracted from indeterminate pulmonary nodules at a baseline CT screening 
scan can be used to predict the subsequent occurrence of cancer or non-cancer with an overall 
accuracy of 80%.   
Importantly, this approach has an accuracy >90% when predicting extreme benign and 
malignant phenotypes; classifications that include more than half of the subjects in this study. 
Currently, prediction of lung cancer risk in a screening setting is achieved using the Lung-
RADSTM system, which classifies risk of cancer from CT scans based on size, solidity and 
location. Lung-RADs was developed for lung cancer screening by the American College of 
Radiology, ACR13. Although Lung-RADSTM was not used in the NLST for prospective 
structured reporting, it was recently evaluated in a large retrospective study,19 resulting in a 
decrease in FPR from 26.6% to 12.8%; hence a significant reduction in the overdiagnosis and 
overtreatment. Sensitivity of detecting a cancer was lower for Lung-RADS vs. the NLST (84.9% 
vs. 93.5%) and this did not appreciably improve upon subsequent follow-up scans. In 
comparison, the radiomics approach herein achieved FPRs of 9% and 11%, sensitivities of 58% 
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and 60% and specificities of 91% and 89% at baseline to predict subsequent cancer 1 and 2 years 
hence, respectively. The most advanced molecular technique used serum miRNA to achieve a 
prediction sensitivity of 87% and specificity of 81%.2 However, most of their sampling was done 
at the time of diagnosis (50 of 69), so its ability to predict across time is unknown. It should be 
noted that our case-control design has a 2:1 mixture of bPN to SDLC for training, which leads to 
a lower FPR, however the training mixture could be changed and so this measurement is 
reported.  
 These results must be tempered by acknowledging the limitations to the current study, 
and areas for improvement exist. The biggest limitations to the current study were cohort sizes, 
non-standardization of image acquisition, and the lack of clinical or molecular data. Although 
there were 26,722 subjects in the LDCT arm of the NLST, only 206 of these subjects developed 
screen-detected lung cancers (SDLC) following a nodule-positive screen. Hence, with these 
relatively small numbers it is difficult to accommodate co-variates of patient characteristics. We 
controlled for these by demographic matching the cohorts under study, but this did not allow for 
analysis of the individual subjects with greater granularity. At baseline, there were a total of 
6,921 NLST participants who had nodule-positive/cancer-negative screens, with 6,715 having 
IPNs that did not develop into lung cancer. Hence, the ratio of non-cancer to eventual-cancer of 
an IPN at baseline is ~32:1. In our cohort analyses, we compared non-cancer to eventual-cancer 
at a ratio of 2:1 and hence, there was a false discovery bias emanating from the proportionalities 
in our study population. While the nested cohort design limits confounding factors, it may also 
limit extrapolation to the larger NLST population. Regarding non-standard imaging, although 
exams in the NLST were supposed to be reconstructed to a slice thickness of 2.0 mm, the actual 
thickness varied from 1 to 5 mm; fields of view (FOV) varied significantly between and within 
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patients (Figures 4.4, 4.5); and reconstruction kernels are not comparable between manufacturers 
(Table 3.4). These issues limit the potential power of radiomics. A further limitation is the time 
required to curate the database, identify the lesions and extract the features. In theory, these 
could be reduced if the data curation and nodule identification occurred at the time of the 
primary radiology read, the so-called “Radiology Reading Room of the Future.”25 Nonetheless, 
even with these caveats, radiomic-based classifier models and risk assessments exhibited 
significant power to identify those patients with IPNs at baseline who are most or least, likely to 
develop cancer. Moving forward, features are being qualified based on their sensitivity to 
reconstruction kernels and overly sensitive features can be removed during dimensionality 
reduction. With very large data sets, these can be parsed as co-variates. While it will be 
preferable to acquire all images with standardized fields of view and reconstruction matrices, this 
is proving to be impractical. To accommodate inter-subject differences, pixel sizes can be 
regularized by interpolation.  
To rectify these deficits large databases will be needed. An important opportunity will be 
the ACR based Lung Cancer Screening Registry (LCSR) to capture screening metadata. Therein 
will be an opportunity to develop a federated, living database of images and radiomic data so that 
co-variates and evolving acquisition standards can be accommodated.  
4.5 Chapter 4 Tables and Figures 
 
Table 4.1: Summary of the highest survival leave-one-out accuracy and AUC results containing 
the feature selection method, number of features, average accuracy, lower quartile accuracy, 
upper quartile accuracy, and the area under the receiver operating curve. LQ is lower quartile and 
UQ is upper quartile. 
Classifier Features # Avg LQ Accy UQ Accy AUC 
Decision 
Tree Top 5 Relief-f 5 77.5 % 65 % 90 % 0.712 
Decision 
Tree Top 10 Relief-f 10 70 % 65 % 75 % 0.732 
Rules All 219 62.5% 65 % 60 % 0.729 
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Table 4.1 (Continued) 
Rules All Top 5 Relief-f 5 75 % 65 % 85 % 0.661 
Naïve 
Bayes All Top 10 Relief-f 10 65 % 55 % 75 % 0.52 
Naïve 
Bayes 
Manual & 
Ensemble test-
retest (.85) Top 5 
RF 
5 60 % 45 % 75 % 0.64 
SVM 
Manual test-retest 
(.90) Top 10 
Relief-f 
10 65 % 70 % 60 % 0.65 
 
Table 4.2: Confusion matrix of the top result, 77.5%, using a decision tree classifier with the top 
five features chosen using Relief-f.  
 Predicted Short Survival Predicted Long Survival 
Actual Short Survival 13 7 
Actual Long Survival 2 18 
 
Table 4.3: Survival leave-one-out accuracy results doing further feature selection on test-retest 
features for decision trees containing the feature selection method, number of features, average 
accuracy, lower quartile accuracy, upper quartile accuracy, and the area under the receiver 
operating curve.  
Classifier Features # Avg Accy LQ Accy UQ Accy AUC 
Decision 
Tree 
Top 5 Relief-f 5 77.5% 65% 90% 0.712 
Top 10 Relief-f 10 70% 65% 75% 0.732 
All Top 5 CFS 5 62.5% 95% 30% 0.292 
All Top 10 CFS 10 65% 75% 55% 0.552 
Manual test-retest (.95) 45 60% 95% 25% 0.271 
Manual test-retest (.90) Top 
10 Relief-f 10 67.5% 70% 65% 0.562 
Manual test-retest (.90) Top 
10 CFS 10 60% 70% 50% 0.435 
Manual test-retest (.85) Top 
5 Relief-f 5 62.5% 85% 40% 0.455 
Manual test-retest (.85) Top 
5 CFS 5 72.5% 95% 50% 0.488 
Manual test-retest (.85) Top 
10 CFS 10 62.5% 70% 55% 0.51 
Ensemble test-retest (.95) 
Top 5 CFS 5 65% 100% 30% 0.3 
Ensemble test-retest (.95) 
Top 10 CFS 10 65% 100% 30% 0.3 
Ensemble test-retest (.90) 
Top 5 CFS 5 62.5% 95% 30% 0.292 
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Table 4.3 (Continued) 
Decision 
Tree 
Ensemble test-retest (.90) 
Top 10 CFS 10 65% 75% 55% 0.524 
Ensemble test-retest (.85) 
Top 5 CFS 5 62.5% 95% 30% 0.292 
Ensemble test-retest (.85) 
Top 10 CFS 10 65% 75% 55% 0.524 
Manual & Ensemble test-
retest (.90) Top 10 Relief-f 10 65% 70% 60% 0.691 
Manual & Ensemble test-
retest (.85) Top 10 Relief-f 10 62.5% 65% 60% 0.68 
 
Table 4.4: Survival leave-one-out accuracy results doing further feature selection on test-retest 
features for JRIP containing the feature selection method, number of features, average accuracy, 
lower quartile accuracy, upper quartile accuracy, and the area under the receiver operating curve.  
Classifier Features # Avg Accy LQ Accy UQ Accy AUC 
Rules 
All 219 62.5% 65% 60% 0.729 
All Top 5 Relief-f 5 75% 65% 85% 0.661 
All Top 10 Relief-f 10 65% 60% 70% 0.598 
Manual test-retest (.90) 
Top 10 Relief-f 10 62.5% 75% 50% 0.568 
Manual test-retest (.85) 95 62.5% 75% 50% 0.688 
 
Table 4.5: Survival leave-one-out accuracy results doing further feature selection on test-retest 
features for Naïve Bayes containing the feature selection method, number of features, average 
accuracy, lower quartile accuracy, upper quartile accuracy, and the area under the receiver 
operating curve.  
Classifier Features # Avg Accy 
LQ  
Accy 
UQ  
Accy AUC 
Naïve 
Bayes 
All Top 5 Relief-f 5 62.5% 45% 80% 0.605 
All Top 10 Relief-f 10 65% 55% 75% 0.52 
Manual test-retest 
(.95) Top 5 Relief-
f 
5 60% 40% 80% 0.458 
Manual test-retest 
(.90) Top 5 Relief-
f 
5 60% 45% 75% 0.54 
Manual & 
Ensemble test-
retest (.95) Top 5 
Relief-f 
5 60% 40% 80% 0.552 
Manual & 
Ensemble test-
retest (.85) Top 5 
RF 
5 60% 45% 75% 0.64 
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Table 4.6: Survival leave-one-out accuracy results doing further feature selection on test-retest 
features for svm containing the feature selection method, number of features, average accuracy, 
lower quartile accuracy, upper quartile accuracy, and the area under the receiver operating curve.  
Classifier Features # Avg Accy LQ  Accy UQ  Accy AUC 
SVM 
Manual test-retest (.90) Top 
10 Relief-f 10 65% 70% 60% 0.65 
Manual & Ensemble test-
retest (.90) Top 5 Relief-f 5 62.5% 65% 60% 0.625 
Manual & Ensemble test-
retest (.90) Top 10 Relief-f 10 60% 65% 55% 0.6 
Manual & Ensemble test-
retest (.85) Top 5 Relief-f 5 62.5% 65% 60% 0.625 
Manual & Ensemble test-
retest (.85) Top 10 Relief-f 10 60% 65% 55% 0.6 
 
Table 4.7: Survival leave-one-out accuracy results using only volume containing the feature 
selection method, number of features, average accuracy, lower quartile accuracy, upper quartile 
accuracy, and the area under the receiver operating curve.  
Classifier Features # Avg Accy LQ Accy UQ Accy AUC 
Decision Tree Volume 1 45% 40% 50% 0.45 
Rules Volume 1 32.5% 45% 20% 0.223 
Naïve Bayes Volume 1 45% 60% 30% 0.388 
SVM Volume 1 15% 20% 10% 0.15 
 
Table 4.8: Stable feature names found from RIDER experiments. 
Feature Name Description 
LongDia Longest Diameter 
ShortAx-LongDia Short Axis Longest Diameter 
ShortAx Short Axis 
Vol-cm Volume 
Area-Pxl Area in pixels 
Volume-pxl Volume In Pixels 
Num-Pxl Number Of Pixels 
Width-Pxl Width In Pixels 
Thickness-Pxl Thickness In Pixels 
Length-Pxl Length In Pixels 
Border-Leng-Pxl Border Length In Pixels 
9c-3D-Compact Shape (Roundness) 
Compactness Shape (Roundness) 
Shape-Index Shape (Roundness) 
9d-3D-AV-Dist-COG-to-Border Location 
9g-3D-Max-Dist-COG-to-Border Location 
10a-3D-Relat-Vol-Airspaces Location 
Mn-Hu Pixel Intensity Histogram 
AvgGLN Grey-Level Non-uniformity 
AvgRLN Run Length Non-uniformity 
AvgRP Average Run Percentage 
3D-Laws-16 Laws Texture 
3D-Laws-41 Laws Texture 
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Table 4.9: Performance of radiomic based prediction classifier models. The one-year prediction of Cohort 1 obtained an accuracy of 
80.12%. The two-year prediction of Cohort 2 obtained an accuracy of 78.78%. Training on cohort one and testing on Cohort 2 
obtained and accuracy of 76.79%. The top accuracy using only volume is also listed. 
Cross 
Validation Classifier 
Feature 
Subset 
Feature 
Selection 
Number of 
Features Accuracy AUC FPR TPR TNR 
10x10-Fold on 
Cohort 1 
J48 RIDER Stable CFS 10 10 76.13% 0.70 0.11 0.5 0.82 
JRIP RIDER Stable CFS 5 5 77.82% 0.72 0.1 0.53 0.9 
NB RIDER Stable CFS 10 10 79.47% 0.79 0.08 0.53 0.92 
Random Forest RIDER Stable None 23 80.12% 0.83 0.09 0.58 0.91 
SVM-Linear 
kernel 
RIDER 
Stable CFS 10 10 79.4% 0.72 0.08 0.52 0.92 
J48 Volume None 1 75.56% 0.72 0.18 0.62 0.82 
10x10-Fold on 
Cohort 2 
J48 All CFS 5 5 76.89% 0.72 0.09 0.52 0.91 
JRIP RIDER Stable None 23 76.18% 0.72 0.12 0.56 0.88 
NB All CFS 10 10 72.88% 0.73 0.08 0.38 0.92 
Random Forest RIDER Stable None 23 77.83% 0.83 0.13 0.62 0.87 
SVM-RBF 
kernel 
RIDER 
Stable RF 10 10 78.78% 0.75 0.11 0.6 0.89 
J48 Volume None 1 71.4% 0.66 0.07 0.32 0.93 
Train on 
Cohort 1 and 
Test on Cohort 
2 
J48 NLST Stable None 37 74.68% 0.62 0.05 0.38 0.95 
JRIP All None 219 72.57% 0.66 0.09 0.4 0.91 
NB NLST Stable CFS 10 10 73.00% 0.63 0.04 0.32 0.96 
Random Forest RIDER Stable RF 10 10 76.79% 0.81 0.18 0.67 0.82 
SVM-RBF 
kernel 
RIDER 
Stable RF 10 10 75.53% 0.73 0.19 0.66 0.81 
JRIP Volume None 1 72.15% 0.63 0.05 0.32 0.95 
FS – Feature selection, 
RIDER Stable– is the intersection of the stable features from manual and ensemble segmentations with CCC > 0.95 on the RIDER data set, 
FPR – false positive rate, 
TPR – True Positive Rate (Sensitivity), 
TNR – True Negative Rate (Specificity). 
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Table 4.10: Percentage accuracy SDLC and bPN Cohort 1 using all 219 image features, RIDER 
stable features, and volume alone.   
Classifier FS All Features RIDER Stable Volume 
J48 None 71.85 73.24 75.56 
J48 RF 5 72.99 71.04  
J48 RF 10 71.27 74.98  
J48 CFS 5 74.8 76.03  
J48 CFS 10 73.15 76.13  
JRIP None 75.94 76.59 75.18 
JRIP RF 5 74.72 74.15  
JRIP RF 10 73.73 75.76  
JRIP CFS 5 75.56 77.82  
JRIP CFS 10 75.38 76.57  
NB None 67.61 79.05 70.23 
NB RF 5 74.3 76.11  
NB RF 10 76.02 78.82  
NB CFS 5 76.95 78.4  
NB CFS 10 76.48 79.47  
SVM-Linear None 76.26 79.24 70.46 
SVM-Linear RF 5 73.95 75.76  
SVM-Linear RF 10 74.57 79.12  
SVM-Linear CFS 5 77.75 79.24  
SVM-Linear CFS 10 77.14 79.4  
SVM-RBF None 77.17 78.66 74.59 
SVM-RBF RF 5 72.92 74.41  
SVM-RBF RF 10 74.14 78.78  
SVM-RBF CFS 5 77.75 78.02  
SVM-RBF CFS 10 76.68 78.52  
Random Forest None 78.47 80.12 70.11 
Random Forest RF 5 68.92 71.23  
Random Forest RF 10 71.69 77.2  
Random Forest CFS 5 74.56 76.01  
Random Forest CFS 10 76.67 77.09  
FS – Feature selection, RIDER Stable– is the intersection of the stable features from manual 
and ensemble segmentations with CCC > 0.95 on the RIDER data set. 
 
Table 4.11: Percentage accuracy SDLC and bPN Cohort 2 using all 219 image features, RIDER 
stable features, and volume alone. 
Classifier FS All Features RIDER Stable Volume 
J48 None 73.04 75.34 71.4 
J48 RF 5 65.31 70.36  
J48 RF 10 68.66 74.59  
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Table 4.11 (Continued) 
J48 CFS 5 76.89 68.22  
J48 CFS 10 75.77 69.8  
JRIP None 69.78 76.18 70.09 
JRIP RF 5 66.45 68.48  
JRIP RF 10 71.08 75.59  
JRIP CFS 5 74.02 67.33  
JRIP CFS 10 72.9 67  
NB None 70.42 69.36 67.56 
NB RF 5 65.39 47.93  
NB RF 10 65.64 70.59  
NB CFS 5 72.07 69.07  
NB CFS 10 72.88 69.2  
SVM-Linear None 73.38 70.67 66.89 
SVM-Linear RF 5 64.15 66.37  
SVM-Linear RF 10 64.07 68.93  
SVM-Linear CFS 5 69.61 67.17  
SVM-Linear CFS 10 69.14 66.96  
SVM-RBF None 77.26 77.69 69.57 
SVM-RBF RF 5 68.14 72.83  
SVM-RBF RF 10 69.86 78.78  
SVM-RBF CFS 5 71.64 69.74  
SVM-RBF CFS 10 72.06 69.74  
Random Forest None 76.7 77.83 62.53 
Random Forest RF 5 67 67.52  
Random Forest RF 10 69.74 77.61  
Random Forest CFS 5 71.28 67.21  
Random Forest CFS 10 74.79 68.26  
FS – Feature selection, RIDER Stable – is the intersection of the stable features from manual 
and ensemble segmentations with CCC > 0.95 on the RIDER data set.  
 
Table 4.12: Percentage accuracy training on Cohort 1 and testing on Cohort 2. 
Classifier FS All Features RIDER Stable NLST Stable Volume 
J48 None 70.04 65.4 74.68 71.73 
J48 RF 5 59.92 67.09 67.51 
 J48 RF 10 62.03 72.15 57.38 
 J48 CFS 5 67.93 70.89 69.62 
 J48 CFS 10 64.56 70.89 73 
 JRIP None 72.57 70.89 70.04 72.15 
JRIP RF 5 67.51 67.51 64.56 
 JRIP RF 10 60.76 67.09 60.34 
 JRIP CFS 5 69.2 67.09 70.89 
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Table 4.12 (Continued) 
JRIP CFS 10 69.62 66.24 70.46 
 NB None 68.35 69.62 71.73 67.09 
NB RF 5 68.35 69.62 63.71 
 NB RF 10 64.56 71.31 57.38 
 NB CFS 5 71.31 72.15 71.31 
 NB CFS 10 70.46 69.62 73 
 SVM-Linear None 71.73 71.73 68.78 67.93 
SVM-Linear RF 5 67.51 71.31 64.14 
 SVM-Linear RF 10 66.67 70.04 65.82 
 SVM-Linear CFS 5 70.46 68.35 68.78 
 SVM-Linear CFS 10 68.78 67.93 70.04 
 SVM-RBF None 71.31 69.2 68.78 68.35 
SVM-RBF RF 5 67.09 68.35 70.04 
 SVM-RBF RF 10 67.51 75.53 67.51 
 SVM-RBF CFS 5 70.46 67.93 68.35 
 SVM-RBF CFS 10 71.31 73.42 67.93 
 Random Forest None 71.31 75.53 74.26 68.78 
Random Forest RF 5 65.4 71.31 66.24 
 Random Forest RF 10 69.62 76.79 69.62 
 Random Forest CFS 5 69.2 68.35 74.68 
 Random Forest CFS 10 70.46 64.98 71.31 
 FS – Feature selection, RIDER Stable– is the intersection of the features from manual  
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable is  
37 features stable across 3 time points for benign tumors.  
 
Table 4.13: Nodule solidity. 
Cohort Ground Glass Semi-Solid Solid 
SDLC 1 11 19 48 
bPN 1 17 7 149 
SDLC 2 13 8 37 
bPN 2 17 7 104 
 
Table 4.14: Risk scores for three approaches from baseline NLST for predicting subsequent 
cancer. Lung-RADS obtained a total accuracy of 71.4%. The McWilliams approach obtained an 
accuracy of 78.9%. The radiomic approach obtained an accuracy of 80.0%. The Volume Only 
approach obtained an accuracy of 71.8%. 
Model Category # Malignant 
# 
Benign Total Accuracy TPR TNR 
Overall Total 58 127 185 
Lung-RADS 
(71.4%) 2 32 99 131 75.6%  
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Table 4.14 (Continued) 
 
3 13 20 33 60.6% 
 
4A 10 7 17 58.8% 
 
4B 3 1 4 75.0%  
Total 58 127 185 71.4% 22.4% 93.7% 
McWilliams 
(78.9%) 
Low 24 98 122 79.7% 
 Intermediate 7 21 28 75.0% 
High 27 8 35 77.1% 
Total 58 127 185 78.9% 46.5% 93.7% 
Radiomics 
(80.0%) 
Low 6 80 86 93.0% 
 
Intermediate-
Low 22 38 60 63.3% 
Intermediate-
High 17 8 25 68.0% 
High 13 1 14 92.9% 
Total 58 127 185 80.0% 51.7% 92.9% 
Volume 
(71.8%) 
Low 17 85 102 83.3% 
 
Intermediate-
Low 13 20 33 60.6% 
Intermediate-
High 5 15 20 25.0% 
High 23 7 30 76.6% 
Total 58 127 185 71.8% 48.2% 82.7% 
Lung RADS categories include: Benign Appearance and Behavior (2), Probably Benign (3), 
and Suspicious (4A, 4B).  
McWilliams categories include: Low, Intermediate, and High 
Radiomics categories include: Low, Intermediate-Low, Intermediate-High, and High 
Volume Only categories include: Low, Intermediate-Low, Intermediate-High, and High 
TPR – True Positive Rate (Sensitivity), TNR – True Negative Rate (Specificity) 
	 56 
Figure 4.1: Kaplan-Meier curve of the predicted survival classes using our best classifier, a 
decision tree with five features selected using Relief-f, p = 0.0219. 
 
 
Figure 4.2: Workflow from image to prediction. Starting with a CT scan, the lungs then nodules 
were segmented.  Features were extracted and used to build predictive models that predicted 
occurrence of cancer or benign nodules in subsequent screens 1 or 2 years hence.
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Figure 4.3: Images of screen-detected lung cancer (SDLC) and benign pulmonary nodules (bPNs) at time 0 (T0) and time 1 (T1). The 
top images are from a patient with a bPN in Cohort 1. The bottom images are from a patient with SDLC in Cohort 1. The T0 scans 
appear similar to the eye, and growth can clearly be seen on the T1 SDLC scan relative to no growth of the T1 bPN scan. Select 
radiomics features from the T0 scans that discriminated the groups are shown in the text boxes. 3D, three-dimensional.  
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(A)      (B) 
 
(C)      (D) 
Figure 4.4: Pixel size histograms per cohort. Pixel sizes were calculated for individual scans in 
(A) SDLC-1, (B) bPN-1, (C) SDLC-2, and (D) bPN-2 groups, showing a wide range of pixel 
sizes from the NLST data. 
 
 
Figure 4.5: Slice thicknesses. This represents the slice thickness for all scans used in this study.  
The majority of cases were of 2.5 mm.
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Figure 4.6: Binary classifier prediction. Receiver operator characteristic (ROC) curves of risk scores for the McWilliams model, our 
random forests–based approach, and the volume-only approach are shown (see text for details). The McWilliams model resulted in an 
area under the ROC of 0.67 and the volume-only approach provided an area under the curve of 0.74, whereas the radiomics classifier 
using random forests resulted in an area under the curve of 0.87. 3D, three-dimensional; NLST, National Lung Screening Trial; 
SDLC, screen-detected lung cancer; bPN, benign pulmonary nodules
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CHAPTER 5: CORRECTION 
 
5.1 Problem 
There was a problem with feature calculations in Definiens that caused four features to be 
computed incorrectly.  This was discovered after the paper “Predicting Malignant Nodules from 
Screening CT Scans”12 which used the data was published. Hence, this Chapter examines the 
problem, correction and change in results. These four features all deal with a nodules distance to 
the pleural wall. A nodules distance can vary. The four features are maximum, average, and 
minimum distance to the pleural wall, and standard deviation of the distance of the nodule to the 
pleural wall. This affected a single case in cohort 2 at time 0. However, the maximum, minimum 
and average distances were listed as 10 km, which affects the normalization of the features.  The 
standard deviation was 0.  When these four features were normalized to between -1 and 1, this 
case had 1 for the maximum, minimum and average features and all the other cases were very 
close to -1 making these features not describe what they were expected to describe. This problem 
did not affect the predictions on survival in the paper “Predicting Outcomes of Nonsmall Cell 
Lung Cancer Using CT Image Features.”8 
5.2 Solution 
The solution to fix these features was to list these four features as missing when they 
were incorrectly computed (i.e. for this case). Different classifiers will handle this in different, 
but appropriate ways. Decision trees split a missing value between paths through the tree, 
weighting the value according to the number of training instances taking that branch. The pieces 
are recombined using weights when they have reached the leaves.48 Random Forests follow the 
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same procedure for missing values as decision trees as they are made up of many decision trees. 
Naïve Bayes can just omit missing values.48 For rule based classifiers such as Ripper missing 
values can be treated similarly to decision tree with one advantage. Missing values can be treated 
as if they didn’t match any tests. This allows an instance containing missing values to be 
deferred until tests are available using other attributes.48 For support vector machines, WLSVM 
and LIBSVM don’t use missing values and data is stored in a sparse format allowing for many 
missing values.56,58  
5.3 Updated Results for Predicting Malignancy 
Cohort 1 was unaffected. Cohort 2 had one case with 4 features that were miscalculated. 
These values were replaced and listed as missing. When training on Cohort 1 and testing on 
Cohort 2 the results can be seen in Table 5.1. These results replace Table 4.12. 10x 10-fold cross 
validations were also performed on Cohort 2. Table 5.2 replaces Table 4.11. Finally, the 
predictions on the subset of Cohort 2 for which Lung-RADS was scored was also recomputed 
the results are in the Table 5.3. 
5.4 Discussion on Predicting Malignancy Corrections 
When training on Cohort 1 and testing on Cohort 2 using updated features the highest 
accuracy improves. Using the same classifier and feature selection as before the accuracy goes 
from 76.79% (AUC = 0.82) to 77.22% (AUC=0.82). Another classifier however now has a 
slightly better accuracy. SVM with an RBF kernel on with the 10 best RIDER stable features 
selected with Relief-f has an accuracy of 77.64% (AUC=0.74).  However, this is not a 
statistically significantly better result. McNemar’s test76 comparing the two results yields a p-
value of 0.055. The best AUC continues to be 0.82 and remains unchanged from the previous 
best. 
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When applying 10x 10-fold cross validation to Cohort 2 the accuracy also improves. The 
previous best accuracy was 78.78% (AUC = 0.75) with an SVM classifier using 10 Relief-f 
features from the RIDER stable features. The previous best AUC was 0.83 with a Random 
Forests classifier using 219 features. The best new accuracy is 79.15% with a support vector 
machine with a RBF kernel using NLST stable features. There was no significant improvement 
in accuracy with McNemar’s test yielding a p-value of 0.5839. The new best AUC is 0.84 with a 
Random Forests classifier using 10 features selected with Relief-f on RIDER stable features.. 
There was no significant improvement in AUC with a Mann-Whitney U test77 yielding a p-value 
of 0.69. 
The model built on the subset of Cohort 2 that had been scored for Lung-RADS 
previously had an accuracy of 80% (AUC=0.87) using a Random Forests classifier. With the 
correction the same classifier has an accuracy of 78.33% (AUC=0.87), but a support vector 
machine classifier with an RBF kernel on 36 NSLT Cohort 2 stable features produces an 
accuracy of 83.8% (AUC=0.78). However, this increase is also not significant and the difference 
has a McNemar’s p-value of 0.3123. The best AUC continues to be 0.87 and remains unchanged 
from the previous best. Correcting the calculation for a nodule’s distance to the pleural wall led 
to a slight increase in accuracy. While this was the case across the board, none of the increases 
were statistically significant at the p=0.05 level.  
5.5 Chapter 5 Tables 
Table 5.1: Corrected percentage accuracy training on Cohort 1 and testing on Cohort 2. 
Classifier FS All Features RIDER Stable NLST Stable Volume 
J48 None 70.46 65.82 75.11 71.73 
J48 RF 5 59.92 67.09 67.51  
J48 RF 10 62.03 74.26 57.38  
J48 CFS 5 67.93 70.89 69.62  
J48 CFS 10 64.56 70.89 76.37  
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Table 5.1 (Continued) 
JRIP None 72.57 70.89 70.89 72.15 
JRIP RF 5 67.51 67.51 64.56  
JRIP RF 10 60.76 67.09 60.34  
JRIP CFS 5 67.93 67.93 70.89  
JRIP CFS 10 69.62 67.51 70.89  
NB None 68.35 70.04 71.31 67.09 
NB RF 5 68.35 69.62 63.71  
NB RF 10 64.56 71.73 57.38  
NB CFS 5 71.31 70.89 71.73  
NB CFS 10 70.89 70.46 73  
SVM-Linear None 72.15 70.46 68.78 67.93 
SVM-Linear RF 5 67.51 71.31 64.14  
SVM-Linear RF 10 66.67 71.73 65.82  
SVM-Linear CFS 5 69.2 67.93 68.78  
SVM-Linear CFS 10 68.78 68.78 69.62  
SVM-RBF None 71.31 70.04 68.78 68.35 
SVM-RBF RF 5 67.09 68.35 70.04  
SVM-RBF RF 10 67.51 77.64 67.51  
SVM-RBF CFS 5 69.62 68.35 68.78  
SVM-RBF CFS 10 71.31 70.04 68.78  
Random Forest None 70.89 75.11 72.57 68.78 
Random Forest RF 5 65.4 71.31 66.24  
Random Forest RF 10 69.62 77.22 69.62  
Random Forest CFS 5 70.89 63.71 76.37  
Random Forest CFS 10 71.31 66.24 74.68  
FS – Feature selection, RIDER Stable– is the intersection of the features from manual 
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable 
is 37 features stable across 3 time points for benign tumors. 
 
Table 5.2: Corrected percentage accuracy SDLC and bPN Cohort 2 using all 219 image features, 
RIDER stable features, and volume alone. 
Classifier FS All 
Features 
RIDER 
Stable 
NLST 
Stable 
Volume 
J48 None 73.04 75.34 73.46 71.4 
J48 RF 5 64.67 70.37 75.22  
J48 RF 10 68.66 74.29 75.18  
J48 CFS 5 76.89 68.22 70.05  
J48 CFS 10 75.77 69.53 69.98  
JRIP None 69.98 75.97 76.46 70.09 
JRIP RF 5 65.92 67.7 70.6  
JRIP RF 10 70.44 75.89 75.17  
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Table 5.2 (Continued) 
JRIP CFS 5 74.02 67.96 68.11  
JRIP CFS 10 73.06 67.21 69.07  
NB None 70.38 69.62 69.24 67.56 
NB RF 5 65.22 46.37 53.93  
NB RF 10 65.32 70.8 71.95  
NB CFS 5 72.07 69.07 70.55  
NB CFS 10 72.92 69.24 70.17  
SVM-Linear None 73.75 70.89 74.3 66.89 
SVM-Linear RF 5 64.15 65.54 66.52  
SVM-Linear RF 10 64.07 68.93 70.72  
SVM-Linear CFS 5 69.61 67.25 69.16  
SVM-Linear CFS 10 69.14 66.99 68.4  
SVM-RBF None 78.04 78.07 79.15 69.57 
SVM-RBF RF 5 68.38 72.97 73.25  
SVM-RBF RF 10 70.15 78.78 79.03  
SVM-RBF CFS 5 71.64 69.91 70.75  
SVM-RBF CFS 10 72.19 69.44 70.17  
Random Forest None 76.49 77.74 76.68 62.53 
Random Forest RF 5 68.48 68.8 69.28  
Random Forest RF 10 70.17 78.88 76.66  
Random Forest CFS 5 73.58 68.44 68.02  
Random Forest CFS 10 76.39 67.66 70.73  
FS – Feature selection, RIDER Stable – is the intersection of the stable features from manual 
and ensemble segmentations with CCC > 0.95 on the RIDER data set. 
 
Table 5.3: Corrected percentage accuracy on Cohort 2 that had a Lung-RADS score 
Classifier FS All Features RIDER Stable NLST Stable Volume 
J48 None 74.53 78.8 77.22 77.72 
J48 RF 5 69.68 74.53 77.84 
 J48 RF 10 72.87 77.25 82.16 
 J48 CFS 5 79.47 77.34 76.17 
 J48 CFS 10 79.36 74.59 76.7 
 JRIP None 73.01 74.97 74.59 76.08 
JRIP RF 5 71.87 74.21 70.2 
 JRIP RF 10 68.65 80.47 81.55 
 JRIP CFS 5 76.23 69.74 73.42 
 JRIP CFS 10 71.84 71.32 72.98 
 NB None 73.51 75.12 74.56 72.43 
NB RF 5 65.99 61.26 41.73 
 NB RF 10 65.5 73.63 77.25 
 NB CFS 5 77.19 74.56 75.09 
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Table 5.3 (Continued) 
NB CFS 10 77.75 74.56 74.56  
SVM-Linear None 80.56 75.73 77.92 70.85 
SVM-Linear RF 5 68.65 73.1 70.88  
SVM-Linear RF 10 68.65 75.2 74.59  
SVM-Linear CFS 5 72.98 71.4 71.96  
SVM-Linear CFS 10 75.12 72.46 72.46  
SVM-RBF None 81.02 83.16 83.8 74.56 
SVM-RBF RF 5 73.45 78.39 77.95  
SVM-RBF RF 10 74.01 79.97 83.25  
SVM-RBF CFS 5 75.61 70.85 72.92  
SVM-RBF CFS 10 73.48 72.98 72.43  
Random Forest None 78.33 79.97 80.47 70.38 
Random Forest RF 5 70.85 75.67 72.95  
Random Forest RF 10 75.58 82.22 79.94  
Random Forest CFS 5 77.31 76.26 74.65  
Random Forest CFS 10 78.3 74.68 74.04  
FS – Feature selection, RIDER Stable– is the intersection of the features from manual  
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable is  
36 features stable across 3 time points for benign tumors on Cohort 2. 
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CHAPTER 6: DATA SCIENCE BOWL 2017 
 
6.1 Introduction 
The Data Science Bowl 201778 presented by Kaggle and Booz Allen Hamilton was an 
open competition to develop lung cancer detection algorithms. To this end awards of $1 million 
were offered, with the top prize being $500,000. The competition was part of the Beau Biden 
Cancer Moonshot.79 Congress passed the 21st Century Cures Act in 2016 allocating $1.8 Billion 
in funding with $300 million to fund Moonshot initiatives in 2017. This competition’s goal was 
the early detection of lung cancer and a reduction in false positives from improved algorithms. 
This goal could help the 225,000 people in the United States lung cancer affects every year and 
also reduce the associated $12 billion in healthcare costs.78 
This competition presented some challenges not seen in our previous work on this topic. 
We were not allowed to use data from the National Lung Screening Trial11 for supplemental 
training data since it was not available to everyone. This NLST data set was our largest data set 
for which we had segmentations for training. Another challenge was that no locations were given 
for the nodules. Our current approach used a seed point within the nodule as a starting point for 
semi-automated segmentation. Because of these challenges it was not clear if the competition 
should be entered which caused a delay in the processing of the data. Still, in the end, we were 
able to compete in a limited way in this competition.  
6.2 Materials and Methods 
The 506 cases of test data were downloaded from Kaggle’s servers and then entered into 
HealthMyne80 software for segmentation by Alberto Garcia from the Moffitt Cancer Center. Two 
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radiologists, Jin Qi and Wei Mu from Moffitt Cancer Center, segmented the lung nodules. 
Mahmoud Abdalah, also from Moffitt Cancer Center, aligned the segmentations with the lung 
images. Saeed Alahamri from the University of South Florida preprocessed the data, cropping 
the images. Rahul Paul from the University of South Florida built a neural network classifier and 
I built a random forests classifier.  
6.2.1 Data 
The competition opened on March 31st 2017 with the release of lung CTs for 1,397 
training cases, 1,035 non-cancer and 362 with cancer, and a validation set of 198 cases. I used a 
script provided by Oleg Trott to generate submissions to determine the validation results.81 
Through repeated submissions the validation set labels were able to be determined. Because the 
leader board gave results for each submission with 5 places of precision, each submission was 
able to deduce 15 labels of the validation set. It was discovered that the validation set included 
72 cases that were labeled as non-cancer and 28 cases with cancer. There was 74% of the 
training set that was not labeled as developing cancer and 72% of the validation set with the 
same label. The algorithms needed to provide a probability from the CT scans whether the 
patient had lung cancer or would develop it in the next 12 months.  
The evaluation metric used to judge an algorithm’s performance was logLoss, which 
penalizes wrong guesses. A lower logLoss is better. The location of nodules was not given and a 
patient could have no nodules or multiple nodules. On April 7th the test set was released. It 
consisted of 506 unlabeled cases. On April 12th the contest concluded. The formula for logLoss78 
is as follows:  
!"#!"$$ = 	− 1) *+,"# *+ + 1 − *+ ,"# 1 − *+.+/0  
where 
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• ) is the number of patients in the test 
• *+ is the predicted probability of the image belonging to a patient with cancer 
• *+ is 1 if the diagnosis is cancer and 0 otherwise 
• ,"# is the natural (base e) logarithm 
6.2.2 Generating Predictions 
Segmentation was performed using Healthmyne80 software.  The software generated 203 
image features. These features can be found in Supplemental Table B.5. These features were 
input into Weka data mining software. A Random Forests classifier was built with 200 decision 
trees trained on the validation set to output predictions on the test set. Another model was built 
also using Random Forests but first selecting the 10 best features using relief-f. We did not have 
the time to run our pipeline on the training data. It required an automatic segmentation of the 
lung and then an automatic nodule finder/segmentor or a number of radiologists with no other 
tasks. 
6.3 Results 
The model built using the Random Forests classifier received a logLoss score of 1.56555. 
The model with Relief-f feature selection received a score of 1.57877. Lower scores are better. 
Rahul Paul’s deep neural network obtained a score of 1.36361. We placed 369th out of 1972 
teams with Rahul’s score. The winning score was 0.39975 by Liao Fangzhou and Zhe Li of 
Tsinghua University.  
6.4 Discussion 
This competition was informative. It highlighted the need to be able to quickly input and 
process large amounts of data. The reliance on human input for segmenting the nodules was a 
bottleneck during the short time window for processing the test set. Also, the competition 
	 69 
showed that the ability to change training sets is important. The NLST data set was the largest 
training set that we had segmented so not using it required processing a new training set. Lastly it 
showed the predictive power of deep convolutional neural networks,82 which the top two teams 
used.  
The winning team of Liao Fangzhou and Zhe Li had an approach that consisted of three 
parts.83 The first part, preprocessing, started with segmenting the lung by applying a Gaussian 
filter and then applying a threshold of -600 Hounsfield units. To remove interior artifacts the 
convex hull algorithm and dilation were applied. The final stage of preprocessing normalized the 
intensity of Hounsfield units to 0 to 255. Training data was obtained from this competition as 
well as the LUNA1684 data set.  
The second part of the algorithm was nodule detection. For this the winners used a 3D 
convolutional neural network. For training, inputs were cube shapes cropped to 128x128x128. 
These patches were selected to include 70% with nodules and 30% without nodules. Flipping the 
image and resizing it augmented training data. Larger nodules were sampled with a higher 
frequency to increase their number in the training set, as they were considered more predictive. 
Hard negative sampling, where negative examples are built from false positives, was used to aid 
performance.  
Negative examples were randomly selected and ranked for classification and the top 
examples used as hard negatives. The detector network was based on U-Net85 and was comprised 
of 5 groups of 32x32x32 blocks and three different scales: 10mm, 30mm, and 60mm.  
The last part of the algorithm was classification. After nodule detection, the top 5 
candidate cubes of 32x32x32 were selected along with a dummy nodule in case segmentation 
missed some nodules. Then max pooling was performed over the central 2x2x2 voxels and the 
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result was passed to two fully connected layers. The final prediction accounts for the probability 
of the dummy nodule as well as an additional loss parameter to facilitate training.  
The second place team, which consisted of Daniel Hammack and Julian de Wit, came up 
with two algorithms and then combined them with a weighted average. Daniel Hammack noted 
that scans were around 30cmx30cm x40cm while a nodule, which can change the diagnosis, was 
around 1cm3 or 1/36,000 of the whole scan. The author’s algorithms consisted of four steps.86 
First he normalized for size to 1mm3 per voxel and intensity from a minimum of -1000 
Hounsfield units mapping to 0 and a maximum of 400 Hounsfield units mapping to 1. The 
second step consisted of detecting candidate nodule regions. Regions of 64mm3 were scored and 
the top 50 chosen. The third step was to extract attributes: diameter, lobulation, spiculation, and 
malignancy. Malignancy was the most important feature but the other features improved upon 
malignancy when used alone. The author also notes that nodules found in the superior lobe were 
more likely to be cancerous. A 3D convolutional neural network was built with leaky RELU and 
max pooling layers. Training data was augmented with data from LUNA1684 as well as rotating 
the contests training data.  
The algorithm by Julian de Wit accounted for the second half of this team’s solution.87 
His solution preprocesses the data in a similar way to his partner, normalizing voxels at 1mm3 
and normalizing Hounsfield Units from 0 to1. The author stressed that in this competition 
building the training set was perhaps the most important part. The training set was built from 
5000 positive labels from LIDC34 weighted 5 times, 400,000 candidates from LUNA16,84 15,000 
non-lung tissue edges of segmentation masks to learn the lung borders, and 7,000 LUNA16 false 
positives weighted 3 times. The competition data segmented by the author was used for a second 
model. The architecture for the neural network took a receptive field of 32mm.3 Next, average 
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pooling of the z-axis to 2mm per voxel was performed. After that, 3D convolution layers with 
RELU and max pooling layers were alternated four times. Finally a bottleneck layer was added 
to train on intermediate features. As an addition the author added a strange nodule detector by 
training a U-Net85 with examples from LUNA16.84 To detect large nodules the network predicted 
at three scales: 1, 1.5, and 2 levels of zoom. Finally the resulting prediction was averaged with 
Daniel Hammock’s algorithm. 
The top two teams used 3D neural networks for nodule detection. This approach was well 
suited to this competition. Competitions like this one help to point out weaknesses in our 
workflow for classification. This competition was good practice for future competitions and 
introduced novel ways of viewing lung cancer classification.  
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CHAPTER 7: CONCLUSIONS 
 
 This dissertation presents an overview of radiomics and how it can be applied to lung 
cancer. The challenges facing radiomics were presented as well as the current methods being 
used to score CT scans. Both old and new articles on radiomics were examined as well as some 
of the data sets used in these studies. Segmentation methods, classifiers, feature selectors, 
performance metrics were also explained. Radiomics represents a promising avenue for research.   
 In my research I have focused on applying radiomic methods in lung cancer prediction 
problems. With a decision tree classifier, adenocarcinoma patients with survival rates in the 
lowest quartile were able to be differentiated from those in the longest surviving quartile with 
77.5% accuracy.8 In another study, a radiomic model was able to predict whether a nodule was 
benign or malignant using data from the National Lung Screening Trial at 80% accuracy.12  
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CHAPTER 8: FUTURE WORK 
 
8.1 Automated Nodule Detection 
Segmenting is the first step of processing images for radiomic use and as such the 
subsequent steps rely on an accurate segmentation. For this reason this work so far has relied on 
the skill of radiologists to detect nodules and then segment the nodules. The radiologists are 
aided by semi-automated methods of segmentation such as the “click and grow” algorithm but 
they still must first find the nodule, click on it, and then make corrections to the resulting 
segmentation.  In practice this is a time consuming bottleneck to the radiomics workflow that 
was highlighted in the Data Science Bowl. A solution to this bottleneck is fully automated 
nodule detection and segmentation. This was the approach utilized by the winners of the Data 
Science Bowl.  
 It is fairly easy to over detect nodules. Having a threshold of intensity will yield many 
nodules from a scan. The problem is reducing the number of false positives. To solve over 
detection a classifier can be employed to classify voxels and learn what is and is not a nodule. 
Shih-Chung et al. utilized this approach of nodule detection with a back-propagation neural 
network.88 They were able to obtain an AUC of 0.645 though their training set was rather small. 
They trained on 60 nodules and tested on 174 nodules. 
The winners of the Data Science Bowl, Liao Fangzhou and Zhe Li, coped with the 
problem of over detection by choosing the top 5 candidate nodules to use in their classification.  
The process of automated detection has room for growth and would go a long way to providing 
fully automated classification.  
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8.2 Neural Network Classification 
Another avenue for improvement in the radiomics workflow is to find a more accurate 
classifier. Neural networks have shown promise for their accuracy. Rahul Paul et al. improved 
upon the accuracy of classifying short and long survival classes on a data set of 40 diagnostic 
computed tomography images from Moffitt Cancer Center.89 Previously the best accuracy was 
77.5% obtained using a decision tree classifier.8  
The approach was to use neural network to extract deep features from a network trained 
on other images. This is known as transfer learning when previous knowledge learned during 
training is applied to a new unrelated topic. The transfer learning training set came from 
ImageNet database.90 The trained MatConvNet convolutional neural network that performed the 
best was vgg-f. 
The design of the neural network consisted of five convolutional layers followed by 3 
fully connected layers using a rectified linear unit (ReLU) as an activation function and dropout, 
where random weights are not allowed to change. Features were obtained from the last hidden 
layer. The architecture of the neural network is further describe in the work by Srivastava et al.91 
and Dumoulin et al.92 The initial accuracy from extracted deep features matched the previous 
accuracy of 77.5% however when deep features were combined with the previous image 
features, an accuracy of 90% was obtained.   
A random forests classifier was used with the 10 best features chosen using symmetric 
uncertainty to rank the features. Five features were chosen from the deep features and five 
features were chosen from the previously used quantitative image features. There is room for 
improvement as the architecture and tuning of neural network improves. More accurate 
classifiers, like neural networks, can improve the usefulness of radiomic decision support. 
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8.3 Nodule Size Informed Classification 
Another promising approach is to divide nodules into groups by size before classification. 
This is the tact employed by Cherezov et al. to improve classification accuracy on the NLST data 
set.93 The data set utilized was the National Lung Screening Trial cohorts used in the paper by 
Hawkins et al.12 and described in the abstract by Schabath et al.10 In total there were 261 cases in 
Cohort 1 and 237 cases in Cohort 2. The data set was divided into small nodules less than 8mm, 
medium nodules 8mm or greater but less than 16mm, and large nodules 16mm or greater.  
These three groups where classified with one of the following methods: decision trees, 
rule based classification, Naïve Bayes, support vector machine with a radial basis function kernel 
or linear kernel and cost and gamma chosen with a grid search, or random forests. Feature sets 
consisted of 219 features extracted with Definiens describing size, shape, location, and texture,69 
a subset of those including 23 features found to be stable on the RIDER data set in the paper by 
Balagurunathan et al.,64 and 37 features found to be stable on Cohort 1.  
In the first experiment used all sizes of Cohort 1 to test on the different groups of sizes 
for Cohort 2. In this case large nodules in Cohort 2 were predicted the most accurately at 81.48% 
compared to 73.22% for small and 74.69% for medium sized nodules and 74.68% overall. This 
experiment was performed with a support vector machine and radial basis function kernel and 
the RIDER stable features subset further selected to the 10 best features using Relief-f.  
In the next experiment, the training data was separated by size and applied to the test data 
of the corresponding size. In this way, overall accuracy, computed as the summation of 
confusion matrices, rose to 81.01%. Three different classifiers were use: for small nodules Naïve 
Bayes with the top 5 features found with relief-f from the RIDER stable features, for the medium 
nodules a support vector machine with a radial basis function kernel with the top 10 features 
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found with Relief-f from the RIDER stable features, and for large nodules Random Forests with 
the top 5 features found with Relief-f from the Cohort 1 stable features.  
Being able to select different classifiers for different sized nodules improved accuracy 
nearly 7%, from 74.68% to 81.01%. With AUC as the criteria for comparison, the results were 
less pronounced. AUC was improved from 0.78 with a random forests classifier when using all 
of Cohort 1 for training to 0.81 with all three sizes using a Naïve Bayes classifier. This result was 
improved slightly to 0.82 AUC when SMOTE94 was applied to generate more minority class 
cases for training.   
The number of features that were the same between classifiers for different sizes was 
small with the notable exception of features for medium nodules compared to features for all 
nodules that had an overlap of 8 of the 10 features. The standard deviation of accuracy and AUC 
was higher for classifiers than it was for features showing that the classifiers play a more 
prominent role than features when dividing by nodule size.  
These improvements in accuracy and AUC from classifying nodules differently based on 
their size shows a promising method for improvement. Different classifiers could be used for 
only some of the sizes. Other types of classifiers such as neural networks could also be used.   
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APPENDIX B: SUPPLEMENTAL TABLES 
 
Table B.1: NLST patient IDs (PIDs) for each cohort. 
SDLC
1 PIDs 
100012,100147,100913,100954,101068,102488,102658,104208,104386,104683,104
815,105340,105974,107058,107434,107682,108352,109345,109573,109589,110253
,110987,111835,112258,112575,112901,115174,116279,116289,116837,117025,11
7820,118681,119358,119743,119924,120790,120954,121169,121999,122364,12351
5,124436,124864,125378,126792,126955,127400,127619,129553,130033,131174,1
31486,131979,133786,134257,200056,200397,201979,204694,204711,205687,2059
00,206359,207584,207647,207782,207857,208801,209029,209095,209512,209831,
212222,213413,213544,213630,213754,214728,215151,216160,216940,217245,217
877,218391 
bPN 1 
PIDs 
100186,100965,101012,101444,101467,101859,101996,102038,102082,102140,102
315,102371,102516,102607,102620,102629,103303,103361,103458,103721,104250
,104302,104705,105042,105071,105085,105148,105205,105526,105808,105941,10
5949,106058,106990,107232,107237,107955,108392,108474,108504,108527,10857
7,108714,108834,108937,109237,109389,109538,109878,109897,109957,110522,1
10846,110878,111121,111200,111702,112183,112390,112957,113308,113665,1138
57,114263,114323,114958,115017,116329,116332,116420,117453,117947,118012,
118145,118226,118743,119173,119343,119958,120358,120378,120556,120762,121
130,121341,121438,121738,121967,122352,122392,122492,122541,122549,122652
,122766,122836,122965,123018,123344,123459,123559,123740,123909,125923,12
5982,126144,126254,126265,127000,127414,127886,128024,128275,128564,12882
9,129140,129741,130139,130231,130352,130544,130689,130692,130869,131122,1
31124,131465,131537,131800,132526,132529,132969,133700,134120,200525,2016
32,201701,202570,203168,203231,203372,203512,203578,203852,203981,204335,
204438,204604,204836,204859,205415,205617,205806,206344,206483,206809,208
107,208287,208794,209676,210231,210528,211423,211696,212827,212831,212849
,213038,213769,214097,214377,214487,214632,216308,218248,218666 
SDLC
2 PIDs 
100658,100681,101192,101428,101692,103359,103621,104999,105165,106194,106
553,107211,107910,108061,109965,111454,112506,113820,115020,115571,117950
,118297,118553,118602,118719,119129,120070,120393,120573,121852,122117,12
2376,122590,123810,123891,124323,125727,126823,128899,129511,129534,13161
1,131963,132313,132823,133076,134491,134503,200129,200221,200628,200925,2
02611,202748,202814,202822,203536,203759,204513,206737,206870,207830,2091
19,209445,210090,210419,210612,210653,210754,211965,212202,212522,212718,
213439,213442,213734,214553,214672,214700,215316,215325,216422,216973,217
203,218510 
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Table B.1 (Continued) 
bPN 2 
PIDs 
100005,100095,100414,100629,100727,101321,101563,101694,102154,102641,102
691,103239,103874,104355,104377,104769,104792,104871,105617,105632,106226,
106957,107579,107725,108320,108461,108539,108600,108921,109031,109127,110
286,110775,110802,110919,110994,111452,112180,112220,112606,112786,112961,
113014,113871,114517,114656,114796,115123,115175,115772,115794,116383,117
406,117490,117610,118243,118745,119485,119533,119568,119894,119934,120593,
120885,121588,121657,121854,122078,122159,122378,122577,123062,123281,123
884,124607,124913,125028,125413,125697,125898,126101,126581,126622,126718,
126814,126928,127048,127731,127996,128033,128535,128601,128714,128852,129
703,129734,130117,130173,130896,130950,131986,132535,132885,133207,133308,
133789,133991,134309,200268,200834,201368,201446,201737,201890,202709,202
873,203344,203921,203930,204238,204377,204494,205023,205964,206925,208147,
209137,209318,209852,210198,210362,210483,210700,211092,212200,213139,213
215,214270,215213,215446,215626,215687,216089,216411,216666,216790,217021,
217676,218217,218320,218383,218662 
 
Table B.2: 3D Image features computed with Definiens software. 
Longest 
Diameter 
[mm] 
Area (Pxl) 3D Laws features  
E5 L5 L5 Layer 1 
3D Laws features  R5 L5 
W5 Layer 1 
3D Wavelet decomposition.  P2 
L2 C10 Layer 1 
Short Axis * 
Longest 
Diameter 
[mm²] 
Volume (Pxl) 3D Laws features  
E5 L5 R5 Layer 1 
3D Laws features  R5 R5 E5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C11 Layer 1 
Short Axis 
[mm] 
Number of pixels 3D Laws features  
E5 L5 S5 Layer 1 
3D Laws features  R5 R5 L5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C12 Layer 1 
Mean [HU] Width (Pxl) 3D Laws features  
E5 L5 W5 Layer 1 
3D Laws features  R5 R5 R5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C13 Layer 1 
StdDev [HU] Thickness (Pxl) 3D Laws features  
E5 R5 E5 Layer 1 
3D Laws features  R5 R5 S5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C14 Layer 1 
Volume [cm³] Length (Pxl) 3D Laws features  
E5 R5 L5 Layer 1 
3D Laws features  R5 R5 
W5 Layer 1 
3D Wavelet decomposition.  P2 
L2 C15 Layer 1 
5a_3D_MacS
pic_NumberO
f 
Length/Thickness 3D Laws features  
E5 R5 R5 Layer 1 
3D Laws features  R5 S5 E5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C1 Layer 1 
8a_3D_Is_Att
ached_To_Ple
ural_Wall 
Length/Width 3D Laws features  
E5 R5 S5 Layer 1 
3D Laws features  R5 S5 L5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C2 Layer 1 
8b_3D_Relati
ve_Border_T
o_Lung 
Border length (Pxl) 3D Laws features  
E5 R5 W5 Layer 1 
3D Laws features  R5 S5 R5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C3 Layer 1 
8c_3D_Relati
ve_Border_T
o_PleuralWall 
avgCoocurrence-Homo 3D Laws features  
E5 S5 E5 Layer 1 
3D Laws features  R5 S5 S5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C4 Layer 1 
8d_3D_Ratio
_Free_To_Att
ached 
avgCoocurrence-MP 3D Laws features  
E5 S5 L5 Layer 1 
3D Laws features  R5 S5 
W5 Layer 1 
3D Wavelet decomposition.  P2 
L2 C5 Layer 1 
9a_3D_Fracti
onalAnisotrop
y 
avgCoocurrence-
contrast 
3D Laws 
features  E5 
S5 R5 Layer 
1 
3D Laws features  
L5 R5 S5 Layer 1 
3D Laws 
features  R5 
W5 E5 Layer 
1 
3D Laws 
features  S5 
S5 L5 
Layer 1 
3D Laws 
features  
W5 R5 R5 
Layer 1 
3D Wavelet 
decomposition.  
P2 L2 C6 Layer 
1 
9b_3D_Circul
arity 
avgCoocurrence-
energy 
3D Laws 
features  E5 
S5 S5 Layer 
1 
3D Laws features  
L5 R5 W5 Layer 1 
3D Laws 
features  R5 
W5 L5 Layer 
1 
3D Laws 
features  S5 
S5 R5 
Layer 1 
3D Laws 
features  
W5 R5 S5 
Layer 1 
3D Wavelet 
decomposition.  
P2 L2 C7 Layer 
1 
9c_3D_Comp
actness 
avgCoocurrence-
entropy 
3D Laws 
features  E5 
S5 W5 Layer 
1 
3D Laws features  
L5 S5 E5 Layer 1 
3D Laws 
features  R5 
W5 R5 
Layer 1 
3D Laws 
features  S5 
S5 S5 
Layer 1 
3D Laws 
features  
W5 S5 E5 
Layer 1 
3D Wavelet 
decomposition.  
P2 L2 C8 Layer 
1 
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Table B.2 (Continued) 
9d_3D_AV_
Dist_COG_T
o_Border_[m
m] 
avgCoocurrence-
mean 
3D Laws 
features  E5 
W5 E5 Layer 
1 
3D Laws features  
L5 S5 L5 Layer 1 
3D Laws 
features  R5 
W5 S5 Layer 
1 
3D Laws 
features  S5 
S5 W5 
Layer 1 
3D Laws 
features  
W5 S5 L5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C11 
Layer 1 
9e_3D_SD_D
ist_COG_To_
Border_[mm] 
avgGLN 3D Laws 
features  E5 
W5 L5 Layer 
1 
3D Laws features  
L5 S5 R5 Layer 1 
3D Laws 
features  R5 
W5 W5 
Layer 1 
3D Laws 
features  S5 
W5 E5 
Layer 1 
3D Laws 
features  
W5 R5 W5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C10 
Layer 1 
9f_3D_MIN_
Dist_COG_T
o_Border_[m
m] 
avgHGRE 3D Laws 
features  E5 
W5 R5 
Layer 1 
3D Laws features  
L5 S5 S5 Layer 1 
3D Laws 
features  S5 
E5 E5 Layer 
1 
3D Laws 
features  S5 
W5 L5 
Layer 1 
3D Laws 
features  
W5 S5 R5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C12 
Layer 1 
9g_3D_MAX
_Dist_COG_
To_Border_[
mm] 
avgLGRE 3D Laws 
features  E5 
W5 S5 Layer 
1 
3D Laws features  
L5 S5 W5 Layer 1 
3D Laws 
features  S5 
E5 L5 Layer 
1 
3D Laws 
features  S5 
W5 R5 
Layer 1 
3D Laws 
features  
W5 S5 S5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C13 
Layer 1 
10a_3D_Relat
ive_Volume_
AirSpaces 
avgLRE 3D Laws 
features  E5 
W5 W5 
Layer 1 
3D Laws features  
L5 W5 E5 Layer 1 
3D Laws 
features  S5 
E5 R5 Layer 
1 
3D Laws 
features  S5 
W5 S5 
Layer 1 
3D Laws 
features  
W5 S5 W5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C14 
Layer 1 
10b_3D_Num
ber_AirSpace
s 
avgLRHGE 3D Laws 
features  L5 
E5 E5 Layer 
1 
3D Laws features  
L5 W5 L5 Layer 1 
3D Laws 
features  S5 
E5 S5 Layer 
1 
3D Laws 
features  S5 
W5 W5 
Layer 1 
3D Laws 
features  
W5 W5 E5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C15 
Layer 1 
10c_3D_Av_
Volume_AirS
paces_[mm³] 
avgLRLGE 3D Laws 
features  L5 
E5 L5 Layer 
1 
3D Laws features  
L5 W5 R5 Layer 1 
3D Laws 
features  S5 
E5 W5 Layer 
1 
3D Laws 
features  
W5 E5 E5 
Layer 1 
3D Laws 
features  
W5 W5 L5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C1 Layer 
1 
10d_3D_SD_
Volume_AirS
paces_[mm³] 
avgRLN 3D Laws 
features  L5 
E5 R5 Layer 
1 
3D Laws features  
L5 W5 S5 Layer 1 
3D Laws 
features  S5 
L5 E5 Layer 
1 
3D Laws 
features  
W5 E5 L5 
Layer 1 
3D Laws 
features  
W5 W5 R5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C2 Layer 
1 
Asymmetry avgRP 3D Laws 
features  L5 
E5 S5 Layer 
1 
3D Laws features  
L5 W5 W5 Layer 
1 
3D Laws 
features  S5 
L5 L5 Layer 
1 
3D Laws 
features  
W5 E5 R5 
Layer 1 
3D Laws 
features  
W5 W5 S5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C3 Layer 
1 
Compactness avgSRE 3D Laws 
features  L5 
E5 W5 Layer 
1 
3D Laws features  
R5 E5 E5 Layer 1 
3D Laws 
features  S5 
L5 R5 Layer 
1 
3D Laws 
features  
W5 E5 S5 
Layer 1 
3D Laws 
features  
W5 W5 W5 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C4 Layer 
1 
Density avgSRHGE 3D Laws 
features  L5 
L5 E5 Layer 
1 
3D Laws features  
R5 E5 L5 Layer 1 
3D Laws 
features  S5 
L5 S5 Layer 
1 
3D Laws 
features  
W5 E5 W5 
Layer 1 
Histogram  
Mean 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C5 Layer 
1 
Elliptic Fit avgSRLGE 3D Laws 
features  L5 
L5 L5 Layer 
1 
3D Laws features  
R5 E5 R5 Layer 1 
3D Laws 
features  S5 
L5 W5 Layer 
1 
3D Laws 
features  
W5 L5 E5 
Layer 1 
Histogram  
SD Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C6 Layer 
1 
Main 
direction 
3D Laws features  
E5 E5 E5 Layer 
1 
3D Laws 
features  L5 
L5 R5 Layer 
1 
3D Laws features  
R5 E5 S5 Layer 1 
3D Laws 
features  S5 
R5 E5 Layer 
1 
3D Laws 
features  
W5 L5 L5 
Layer 1 
Histogram 
ENERGY 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C7 Layer 
1 
Radius of 
largest 
enclosed 
ellipse  
3D Laws features  
E5 E5 L5 Layer 
1 
3D Laws 
features  L5 
L5 S5 Layer 
1 
3D Laws features  
R5 E5 W5 Layer 1 
3D Laws 
features  S5 
R5 L5 Layer 
1 
3D Laws 
features  
W5 L5 R5 
Layer 1 
Histogram 
ENTROPY 
Layer 1 
3D Wavelet 
decomposition.  
P1 L2 C8 Layer 
1 
Radius of 
smallest 
enclosing 
ellipse 
3D Laws features  
E5 E5 R5 Layer 
1 
3D Laws 
features  L5 
L5 W5 Layer 
1 
3D Laws features  
R5 L5 E5 Layer 1 
3D Laws 
features  S5 
R5 R5 Layer 
1 
3D Laws 
features  
W5 L5 S5 
Layer 1 
Histogram KUR Layer 1 
Shape index 3D Laws features  
E5 E5 S5 Layer 
1 
3D Laws 
features  L5 
R5 E5 Layer 
1 
3D Laws features  
R5 L5 L5 Layer 1 
3D Laws 
features  S5 
R5 S5 Layer 
1 
3D Laws 
features  
W5 L5 W5 
Layer 1 
Histogram SKEW Layer 1 
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Table B.2 (Continued) 
Roundness 3D Laws features  
E5 E5 W5 Layer 
1 
3D Laws 
features  L5 
R5 L5 Layer 
1 
3D Laws features  
R5 L5 R5 Layer 1 
3D Laws 
features  S5 
R5 W5 
Layer 1 
3D Laws 
features  
W5 R5 E5 
Layer 1 
3D Wavelet decomposition.  P2 
L2 C9 Layer 1 
Rectangular 
Fit 
3D Laws features  
E5 L5 E5 Layer 
1 
3D Laws 
features  L5 
R5 R5 Layer 
1 
3D Laws features  
R5 L5 S5 Layer 1 
3D Laws 
features  S5 
S5 E5 Layer 
1 
3D Laws 
features  
W5 R5 L5 
Layer 1 
3D Wavelet decomposition.  P1 
L2 C9 Layer 1 
 
Table B.3: Image features that were stable on the RIDER data set. 
Feature Category 
Longest Diameter [mm]  Size 
Short Axis * Longest Diameter [mm_]  Size 
Short Axis [mm]  Size 
Mean [HU]  Pixel Histogram 
StdDev [HU]  Pixel Histogram 
Volume [cm_]  Size 
5a_3D_MacSpic_NumberOf  Shape 
8a_3D_Is_Attached_To_Pleural_Wall  Location 
8b_3D_Relative_Border_To_Lung  Location 
8c_3D_Relative_Border_To_PleuralWall  Location 
9b_3D_Circularity  Shape 
9e_3D_SD_Dist_COG_To_Border_[mm]  Location 
9g_3D_MAX_Dist_COG_To_Border_[mm]  Location 
Asymmetry  Shape 
Roundness  Shape 
Volume (Pxl)  Size 
Number of pixels  Shape 
Length/Width  Size 
avgRLN  Co-occurrence and 
Run Length 
3D Laws features  E5 E5 L5 Layer 1  Laws 
3D Laws features  E5 E5 R5 Layer 1  Laws 
3D Laws features  E5 W5 L5 Layer 1  Laws 
3D Laws features  L5 W5 L5 Layer 1  Laws 
 
Table B.4: Image features that were stable on the NLST Cohort 1 time 0 data set 
Longest Diameter [mm] Size 
Short Axis * Longest Diameter 
[mm_] 
Size 
Short Axis [mm] Size 
Mean [HU] Pixel Histogram 
Volume [cm_] Size 
8a_3D_Is_Attached_To_Pleural_Wa
ll 
Location 
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Table B.4 (Continued) 
8b_3D_Relative_Border_To_Lung Location 
8c_3D_Relative_Border_To_Pleural
Wall 
Location 
9c_3D_Compactness Location 
9d_3D_AV_Dist_COG_To_Border
_[mm] 
Location 
9e_3D_SD_Dist_COG_To_Border_
[mm] 
Location 
9f_3D_MIN_Dist_COG_To_Border
_[mm] 
Location 
9g_3D_MAX_Dist_COG_To_Bord
er_[mm] 
Location 
10a_3D_Relative_Volume_AirSpac
es 
Location 
10b_3D_Number_AirSpaces Location 
10c_3D_Av_Volume_AirSpaces_[
mm_] 
Location 
Compactness Shape 
Shape index Shape 
Area (Pxl) Size 
Volume (Pxl) Size 
Number of pixels Size 
Width (Pxl) Size 
Thickness (Pxl) Size 
Length (Pxl) Size 
Border length (Pxl) Size 
avgGLN Co-occurrence and Run Length 
avgHGRE Co-occurrence and Run Length 
avgLRHGE Co-occurrence and Run Length 
avgRLN Co-occurrence and Run Length 
avgRP Co-occurrence and Run Length 
avgSRHGE Co-occurrence and Run Length 
3D Laws features  L5 L5 L5 Layer 1 Laws 
Histogram ENTROPY Layer 1 Pixel Histogram 
Histogram SKEW Layer 1 Pixel Histogram 
3D Wavelet decomposition.  P2 L2 
C13 Layer 1 
Wavelets 
3D Wavelet decomposition.  P2 L2 
C14 Layer 1 
Wavelets 
3D Wavelet decomposition.  P2 L2 
C15 Layer 1 
Wavelets 
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Table B.5: 203 Health Myne image features. 
AVG_DENSITY GLCM_CONTR
AST_HU_POSX
POSZ 
GLCM_HOMOGE
NEITY_HU_POS
X 
GLCM_VARIAN
CE_HU_NEGXPO
SZ 
L2_DISTANCE_
MM 
LARGEST_DIAM
ETER_START_V
OXELS_Y 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
MM_Y 
PERCENT_SOLI
D_INCL_AIR 
VOLUME_ML 
CENTROID_X_
MM 
GLCM_CONTR
AST_HU_POSY 
GLCM_HOMOGE
NEITY_HU_POS
XPOSY 
GLCM_VARIAN
CE_HU_NEGYPO
SZ 
L2_UNIT_AXIS_
X_MM 
LARGEST_DIAM
ETER_START_V
OXELS_Z 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
MM_Z 
RECIST_PATIEN
T_NADIR 
VOLUME_MM3 
CENTROID_Y_
MM 
GLCM_CONTR
AST_HU_POSY
POSZ 
GLCM_HOMOGE
NEITY_HU_POS
XPOSZ 
GLCM_VARIAN
CE_HU_POSX 
L2_UNIT_AXIS_
Y_MM 
LARGEST_DIAM
ETER_VOXELS 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_X 
RECIST_PERCEN
T_CHANGE_FRO
M_BL 
VOLUME_VOX
ELS 
CENTROID_Z_
MM 
GLCM_CONTR
AST_HU_POSZ 
GLCM_HOMOGE
NEITY_HU_POS
Y 
GLCM_VARIAN
CE_HU_POSXPO
SY 
L2_UNIT_AXIS_
Z_MM 
LARGEST_PLAN
AR_DIAMETER_
END_MM_X 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_Y 
RECIST_PERCEN
T_CHANGE_FRO
M_NADIR 
 
COMPACTNESS
1_MM 
GLCM_ENERG
Y_HU_NEGXPO
SY 
GLCM_HOMOGE
NEITY_HU_POS
YPOSZ 
GLCM_VARIAN
CE_HU_POSXPO
SZ 
L3_AXIS_END_X
_MM 
LARGEST_PLAN
AR_DIAMETER_
END_MM_Y 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_Z 
RECIST_SCORE_
PATIENT 
 
COMPACTNESS
2_MM 
GLCM_ENERG
Y_HU_NEGXPO
SZ 
GLCM_HOMOGE
NEITY_HU_POS
Z 
GLCM_VARIAN
CE_HU_POSY 
L3_AXIS_END_Y
_MM 
LARGEST_PLAN
AR_DIAMETER_
END_MM_Z 
LARGEST_PLAN
AR_ORTHO_DIA
METER_VOXEL
S 
RECIST_SUM  
ENERGY_HU GLCM_ENERG
Y_HU_NEGYPO
SZ 
GLCM_MEAN_H
U_NEGXPOSY 
GLCM_VARIAN
CE_HU_POSYPO
SZ 
L3_AXIS_END_Z
_MM 
LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_X 
LUNG_RADS RECIST_TARGE
T_LESION 
 
ENTROPY_HU GLCM_ENERG
Y_HU_POSX 
GLCM_MEAN_H
U_NEGXPOSZ 
GLCM_VARIAN
CE_HU_POSZ 
L3_AXIS_START
_X_MM 
LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_Y 
LUNG_RADS_DI
AMETER_MM 
RECIST_TIME_P
OINT 
 
FOOTPRINT_X_
MM 
GLCM_ENERG
Y_HU_POSXPO
SY 
GLCM_MEAN_H
U_NEGYPOSZ 
KURTOSIS_HU L3_AXIS_START
_Y_MM 
LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_Z 
LUNG_RADS_IS
OLATION 
ROOT_MEAN_S
QUARE 
 
FOOTPRINT_Y_
MM 
GLCM_ENERG
Y_HU_POSXPO
SZ 
GLCM_MEAN_H
U_POSX 
L1_AXIS_END_X
_MM 
L3_AXIS_START
_Z_MM 
LARGEST_PLAN
AR_DIAMETER_
MM 
LUNG_RADS_RE
ASONING_CODE 
SEED_POINT_US
ER_GRID_X 
 
FOOTPRINT_Z_
MM 
GLCM_ENERG
Y_HU_POSY 
GLCM_MEAN_H
U_POSXPOSY 
L1_AXIS_END_Y
_MM 
L3_DISTANCE_
MM 
LARGEST_PLAN
AR_DIAMETER_
START_MM_X 
MASS_GRAMS SEED_POINT_US
ER_GRID_Y 
 
GLCM_AUTOC
ORRELATION_
HU_NEGXPOSY 
GLCM_ENERG
Y_HU_POSYPO
SZ 
GLCM_MEAN_H
U_POSXPOSZ 
L1_AXIS_END_Z
_MM 
L3_UNIT_AXIS_
X_MM 
LARGEST_PLAN
AR_DIAMETER_
START_MM_Y 
MAX_HU SEED_POINT_US
ER_GRID_Z 
 
GLCM_AUTOC
ORRELATION_
HU_NEGXPOSZ 
GLCM_ENERG
Y_HU_POSZ 
GLCM_MEAN_H
U_POSY 
L1_AXIS_START
_X_MM 
L3_UNIT_AXIS_
Y_MM 
LARGEST_PLAN
AR_DIAMETER_
START_MM_Z 
MAX_VOXELS SEED_POINT_US
ER_PATIENT_X 
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Table B.5 (Continued) 
GLCM_AUTOC
ORRELATION_
HU_NEGYPOS
Z 
GLCM_ENTROP
Y_HU_NEGXPOS
Y 
GLCM_MEAN_H
U_POSYPOSZ 
L1_AXIS_START
_Y_MM 
L3_UNIT_AXIS_
Z_MM 
LARGEST_PLAN
AR_DIAMETER_
START_VOXELS
_X 
MEAN_DEVIATI
ON_HU 
SEED_POINT_US
ER_PATIENT_Y 
 
GLCM_AUTOC
ORRELATION_
HU_POSX 
GLCM_ENTROP
Y_HU_NEGXPOS
Z 
GLCM_MEAN_H
U_POSZ 
L1_AXIS_START
_Z_MM 
LARGEST_DIAM
ETER_END_MM
_X 
LARGEST_PLAN
AR_DIAMETER_
START_VOXELS
_Y 
MEAN_HU SEED_POINT_US
ER_PATIENT_Z 
 
GLCM_AUTOC
ORRELATION_
HU_POSXPOSY 
GLCM_ENTROP
Y_HU_NEGYPOS
Z 
GLCM_STD_HU_
NEGXPOSY 
L1_DISTANCE_
MM 
LARGEST_DIAM
ETER_END_MM
_Y 
LARGEST_PLAN
AR_DIAMETER_
START_VOXELS
_Z 
MEAN_VOXELS SKEWNESS_HU  
GLCM_AUTOC
ORRELATION_
HU_POSXPOSZ 
GLCM_ENTROP
Y_HU_POSX 
GLCM_STD_HU_
NEGXPOSZ 
L1_UNIT_AXIS_
X_MM 
LARGEST_DIAM
ETER_END_MM
_Z 
LARGEST_PLAN
AR_DIAMETER_
VOXELS 
MEDIAN_HU SPHERICAL_DIS
PROPORTION_M
M 
 
GLCM_AUTOC
ORRELATION_
HU_POSY 
GLCM_ENTROP
Y_HU_POSXPOS
Y 
GLCM_STD_HU_
NEGYPOSZ 
L1_UNIT_AXIS_
Y_MM 
LARGEST_DIAM
ETER_END_VOX
ELS_X 
LARGEST_PLAN
AR_ORTHO_DIA
METER_END_M
M_X 
MEDIAN_VOXE
LS 
SPHERICITY_M
M 
 
GLCM_AUTOC
ORRELATION_
HU_POSYPOSZ 
GLCM_ENTROP
Y_HU_POSXPOS
Z 
GLCM_STD_HU_
POSX 
L1_UNIT_AXIS_
Z_MM 
LARGEST_DIAM
ETER_END_VOX
ELS_Y 
LARGEST_PLAN
AR_ORTHO_DIA
METER_END_M
M_Y 
MIN_HU STD_DEV_HU  
GLCM_AUTOC
ORRELATION_
HU_POSZ 
GLCM_ENTROP
Y_HU_POSY 
GLCM_STD_HU_
POSXPOSY 
L2_AXIS_END_X
_MM 
LARGEST_DIAM
ETER_END_VOX
ELS_Z 
LARGEST_PLAN
AR_ORTHO_DIA
METER_END_M
M_Z 
MIN_VOXELS SURFACE_AREA
_MM2 
 
GLCM_CONTRAS
T_HU_NEGXPOS
Y 
GLCM_ENTROPY_
HU_POSYPOSZ 
GLCM_STD_HU_P
OSXPOSZ 
L2_AXIS_END_Y_
MM 
LARGEST_DIAMET
ER_MM 
LARGEST_PLANA
R_ORTHO_DIAME
TER_END_VOXELS
_X 
NODULE_TYPE SURFACE_AREA_
TO_VOLUME_RA
TIO_MM 
GLCM_CONTR
AST_HU_NEGX
POSZ 
GLCM_ENTROP
Y_HU_POSZ 
GLCM_STD_HU_
POSY 
L2_AXIS_END_Z
_MM 
LARGEST_DIAM
ETER_START_M
M_X 
LARGEST_PLAN
AR_ORTHO_DIA
METER_END_V
OXELS_Y 
NORMALIZED_
ABOVE_MEAN_
DEVIATION_HU 
TIME_POINT_RE
LATIVE 
 
GLCM_CONTR
AST_HU_NEGY
POSZ 
GLCM_HOMOGE
NEITY_HU_NEG
XPOSY 
GLCM_STD_HU_
POSYPOSZ 
L2_AXIS_START
_X_MM 
LARGEST_DIAM
ETER_START_M
M_Y 
LARGEST_PLAN
AR_ORTHO_DIA
METER_END_V
OXELS_Z 
PART_SOLID_DI
AMETER_MM 
UNIFORMITY_A
CR 
 
GLCM_CONTR
AST_HU_POSX 
GLCM_HOMOGE
NEITY_HU_NEG
XPOSZ 
GLCM_STD_HU_
POSZ 
L2_AXIS_START
_Y_MM 
LARGEST_DIAM
ETER_START_M
M_Z 
LARGEST_PLAN
AR_ORTHO_DIA
METER_MM 
PERCENT_GGO UNIFORMITY_H
U 
 
GLCM_CONTR
AST_HU_POSX
POSY 
GLCM_HOMOGE
NEITY_HU_NEG
YPOSZ 
GLCM_VARIAN
CE_HU_NEGXPO
SY 
L2_AXIS_START
_Z_MM 
LARGEST_DIAM
ETER_START_V
OXELS_X 
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
MM_X 
PERCENT_SOLI
D 
VARIANCE_HU  
 
